US4203802A
(en)
*
|
1971-05-14 |
1980-05-20 |
Syva Company |
Inhibitable enzyme amplification assay
|
US3875011A
(en)
*
|
1972-11-06 |
1975-04-01 |
Syva Co |
Enzyme immunoassays with glucose-6-phosphate dehydrogenase
|
US3904367A
(en)
*
|
1973-08-15 |
1975-09-09 |
Gen Electric |
Contrast enhancement for immunological film detection
|
US4039652A
(en)
*
|
1973-10-11 |
1977-08-02 |
Miles Laboratories, Inc. |
Column method of immunoassay employing an immobilized binding partner
|
US3951748A
(en)
*
|
1974-11-11 |
1976-04-20 |
Medical Products, Inc. |
Sensitized matrix for detection of disease
|
SE388694B
(sv)
*
|
1975-01-27 |
1976-10-11 |
Kabi Ab |
Sett att pavisa ett antigen exv i prov av kroppvetskor, med utnyttjande av till porost berarmaterial bundna eller adsorberande antikroppar
|
NL7501215A
(nl)
*
|
1975-02-01 |
1976-08-03 |
Akzo Nv |
Methode voor het aantonen en bepalen van een antigeen of antilichaam.
|
IN142734B
(fr)
*
|
1975-04-28 |
1977-08-20 |
Miles Lab |
|
US4016043A
(en)
*
|
1975-09-04 |
1977-04-05 |
Akzona Incorporated |
Enzymatic immunological method for the determination of antigens and antibodies
|
USRE32696E
(en)
*
|
1975-09-04 |
1988-06-14 |
Akzona Incorporated |
Enzymatic immunological method for determination of antigens and antibodies
|
US4642285A
(en)
*
|
1975-09-29 |
1987-02-10 |
Diamedix Corporation |
Sandwich EIA for antigen
|
US4474878A
(en)
*
|
1975-09-29 |
1984-10-02 |
Cordis Laboratories, Inc. |
Sandwich EIA for antigen associated with hepatitis
|
SE7610683L
(sv)
*
|
1975-09-29 |
1977-06-10 |
Cordis Corp |
Metod for bestemning av nervaron av ett antigen associerat med hepatit
|
US4116776A
(en)
*
|
1976-04-19 |
1978-09-26 |
International Radioimmune Systems, Inc. |
Diagnostic blood test and kit for detecting human chorionic gonadotropin
|
GB1572220A
(en)
*
|
1976-10-07 |
1980-07-30 |
Mochida Pharm Co Ltd |
Immunochemical process of measuring physiologically active substances
|
GB1549069A
(en)
*
|
1976-12-10 |
1979-08-01 |
Erba Farmitalia |
Enzyme linked immunoassay
|
JPS5399319A
(en)
*
|
1977-02-09 |
1978-08-30 |
Hidematsu Hirai |
Novel qualitative and quantitative detecting method and detecting body for antgenic substance
|
IT1153999B
(it)
*
|
1977-03-15 |
1987-01-21 |
Snam Progetti |
Composizione atta alla determinazione della triiodotironina e metodo diagnostico impiegante la stessa
|
IL51668A
(en)
*
|
1977-03-16 |
1981-12-31 |
Israel State |
Analytical method for the quantitative determination of immunogens and antibodies and a kit therefor
|
CA1108516A
(fr)
*
|
1977-11-21 |
1981-09-08 |
Stanley E. Charm |
Methode pour detecter les traces d'antibiotiques
|
US4275149A
(en)
*
|
1978-11-24 |
1981-06-23 |
Syva Company |
Macromolecular environment control in specific receptor assays
|
NL7804144A
(nl)
*
|
1978-04-18 |
1979-10-22 |
Akzo Nv |
Inrichting voor clorimetrische bepalingen.
|
NZ190452A
(en)
*
|
1978-05-19 |
1981-04-24 |
Becton Dickinson Co |
Solid phase assay receptor contacted with analyte and then with labeled analyte
|
JPS54170918U
(fr)
*
|
1978-05-23 |
1979-12-03 |
|
|
US4273756A
(en)
*
|
1978-07-28 |
1981-06-16 |
Abbott Laboratories |
Immunoassay for class specific antibodies
|
US4292296A
(en)
*
|
1978-09-12 |
1981-09-29 |
Baxter Travenol Laboratories, Inc. |
Diagnostic method
|
US4240751A
(en)
*
|
1978-11-09 |
1980-12-23 |
Akzona Incorporated |
Method and apparatus for specific binding substances
|
US4318707A
(en)
*
|
1978-11-24 |
1982-03-09 |
Syva Company |
Macromolecular fluorescent quencher particle in specific receptor assays
|
US4374925A
(en)
*
|
1978-11-24 |
1983-02-22 |
Syva Company |
Macromolecular environment control in specific receptor assays
|
JPS55116258A
(en)
*
|
1979-03-01 |
1980-09-06 |
Fuji Photo Film Co Ltd |
Microimmunoassay method
|
JPS55116259A
(en)
*
|
1979-03-01 |
1980-09-06 |
Fuji Photo Film Co Ltd |
Microimmunoassay method
|
US4269938A
(en)
*
|
1979-03-08 |
1981-05-26 |
Eastman Kodak Company |
Assay of peroxidatively active materials
|
US4289748A
(en)
*
|
1979-05-31 |
1981-09-15 |
United States Of America |
Ultrasensitive enzymatic radioimmunoassay method
|
US4347312A
(en)
*
|
1980-03-20 |
1982-08-31 |
Research Triangle Institute |
Detection of antibiotics in milk
|
AU543007B2
(en)
*
|
1980-04-15 |
1985-03-28 |
Technicon Instruments Corportion |
Agglutination immunoassay
|
DE3016575A1
(de)
*
|
1980-04-30 |
1981-11-05 |
Merck Patent Gmbh, 6100 Darmstadt |
Verfahren zur immunologischen bestimmung von enzymen, mittel zur durchfuehrung des verfahrens und seine verwandung
|
US6406920B1
(en)
|
1980-06-20 |
2002-06-18 |
Inverness Medical Switzerland Gmbh |
Processes and apparatus for carrying out specific binding assays
|
EP0111762B1
(fr)
*
|
1980-06-20 |
1987-11-19 |
Unilever Plc |
Procédés et appareil pour l'exécution d'essais de liaisons spécifiques
|
NL185309C
(nl)
|
1980-07-28 |
1990-03-01 |
Akzo Nv |
Methode voor het bepalen van antigenen met behulp van twee of meer monoklonale antilichamen alsmede immuunreagens.
|
US4486530A
(en)
*
|
1980-08-04 |
1984-12-04 |
Hybritech Incorporated |
Immunometric assays using monoclonal antibodies
|
US4376110A
(en)
*
|
1980-08-04 |
1983-03-08 |
Hybritech, Incorporated |
Immunometric assays using monoclonal antibodies
|
US4323647A
(en)
*
|
1980-10-15 |
1982-04-06 |
University Of Miami |
Steric hindrance enzyme immunoassay
|
NZ199286A
(en)
*
|
1980-12-22 |
1986-05-09 |
Commw Serum Lab Commission |
A method of detecting antibodies or an antigenic or haptenic substance in a sample
|
US4517288A
(en)
*
|
1981-01-23 |
1985-05-14 |
American Hospital Supply Corp. |
Solid phase system for ligand assay
|
US4425438A
(en)
*
|
1981-03-13 |
1984-01-10 |
Bauman David S |
Assay method and device
|
GB2095258B
(en)
*
|
1981-03-19 |
1984-09-05 |
Janssen Pharmaceutica Nv |
A bright field light microscopic method of localizing tissue antigens
|
US4592995A
(en)
*
|
1981-03-30 |
1986-06-03 |
Dainippon Pharmaceutical Co., Ltd. |
Reagent for streptococcal anti-esterase assay
|
US4604365A
(en)
*
|
1981-06-02 |
1986-08-05 |
Electro-Nucleonics, Inc. |
Immunoprecipitation assay
|
JPS57193643U
(fr)
*
|
1981-06-03 |
1982-12-08 |
|
|
US4447528A
(en)
*
|
1981-08-10 |
1984-05-08 |
Corning Glass Works |
Detecting intrinsic factor blocking site antibody
|
WO1983000877A1
(fr)
*
|
1981-08-31 |
1983-03-17 |
Icl Scient |
Detection immunohistochimique a l'oxydase de glucose d'anticorps anti-nucleaires
|
US4452886A
(en)
*
|
1981-09-21 |
1984-06-05 |
Henry Robert P |
Novel photon absorbing or emitting polymers and their use as reagents in immunoassay systems
|
US4446232A
(en)
*
|
1981-10-13 |
1984-05-01 |
Liotta Lance A |
Enzyme immunoassay with two-zoned device having bound antigens
|
US4753875A
(en)
*
|
1981-11-02 |
1988-06-28 |
Ryan James W |
Method for assaying proteases with tagged proteinaceous inhibitors
|
US4506009A
(en)
*
|
1982-03-30 |
1985-03-19 |
University Of California |
Heterogeneous immunoassay method
|
US4469787A
(en)
*
|
1982-05-14 |
1984-09-04 |
Mallinckrodt Inc. |
Immunoassay involving soluble complex of second antibody and labeled binding protein
|
US4503143A
(en)
*
|
1982-08-20 |
1985-03-05 |
Btc Diagnostics Limited Partnership |
Enzyme immunoassay with two-part solution of tetramethylbenzidine as chromogen
|
US4530900A
(en)
*
|
1982-09-13 |
1985-07-23 |
Seragen Diagnostics Inc. |
Soluble insoluble polymers in enzymeimmunoassay
|
FR2550799B1
(fr)
*
|
1983-08-17 |
1986-02-21 |
Commissariat Energie Atomique |
Compose marque par une enzyme, son procede de preparation et son utilisation en enzymoimmunologie
|
JPS60501570A
(ja)
*
|
1983-11-08 |
1985-09-19 |
クイデル |
迅速プランジヤ−免疫学的検定法及び装置
|
US4777240A
(en)
*
|
1984-03-08 |
1988-10-11 |
Scripps Clinic And Research Foundation |
SV40 expression vector containing HBxAg as an expression marker
|
US4645828A
(en)
|
1984-03-23 |
1987-02-24 |
Oncogen |
Platelet related growth regulator
|
US4665020A
(en)
*
|
1984-05-30 |
1987-05-12 |
United States Department Of Energy |
Flow cytometer measurement of binding assays
|
US4812395A
(en)
*
|
1984-11-05 |
1989-03-14 |
E. I. Du Pont De Nemours And Company |
Method for detecting enzymatic activity using particle agglutination
|
US4812396A
(en)
*
|
1984-11-05 |
1989-03-14 |
E. I. Du Pont De Nemours And Company |
Method for detecting enzymatic activity using particle agglutination
|
US4713347A
(en)
*
|
1985-01-14 |
1987-12-15 |
Sensor Diagnostics, Inc. |
Measurement of ligand/anti-ligand interactions using bulk conductance
|
US4824784A
(en)
*
|
1985-04-08 |
1989-04-25 |
Hygeia Sciences, Incorporated |
Chromogenic solution for immunoassay
|
US4837395A
(en)
*
|
1985-05-10 |
1989-06-06 |
Syntex (U.S.A.) Inc. |
Single step heterogeneous assay
|
US4931385A
(en)
*
|
1985-06-24 |
1990-06-05 |
Hygeia Sciences, Incorporated |
Enzyme immunoassays and immunologic reagents
|
US4868108A
(en)
*
|
1985-12-12 |
1989-09-19 |
Hygeia Sciences, Incorporated |
Multiple-antibody detection of antigen
|
CH670709A5
(fr)
*
|
1986-04-24 |
1989-06-30 |
Univ Moskovsk |
|
US5334513A
(en)
*
|
1988-05-17 |
1994-08-02 |
Syntex (U.S.A.) Inc. |
Method for immunochromatographic analysis
|
US5039607A
(en)
*
|
1988-05-17 |
1991-08-13 |
Syntex (U.S.A.) Inc. |
Method for immunochromatographic analysis
|
US5102788A
(en)
*
|
1988-11-21 |
1992-04-07 |
Hygeia Sciences, Inc. |
Immunoassay including lyophilized reactant mixture
|
US5135863A
(en)
*
|
1988-12-23 |
1992-08-04 |
Syntex (U.S.A.) Inc. |
Compositions and methods for determining the presence of amphetamines in a sample suspected of containing amphetamine and/or methamphetamine
|
US5614504A
(en)
*
|
1990-08-01 |
1997-03-25 |
The University Of South Florida |
Method of making inosine monophosphate derivatives and immunopotentiating uses thereof
|
WO1992020820A1
(fr)
*
|
1991-05-15 |
1992-11-26 |
Vanderbilt University |
Methode de determination du potentiel metastatique des cellules tumorales
|
US5348867A
(en)
*
|
1991-11-15 |
1994-09-20 |
George Georgiou |
Expression of proteins on bacterial surface
|
US5874423A
(en)
*
|
1992-09-10 |
1999-02-23 |
Yissum Research Development Co. Of The Hebrew University Of Jerusalem |
Digitalis-like compounds
|
US5801005A
(en)
|
1993-03-17 |
1998-09-01 |
University Of Washington |
Immune reactivity to HER-2/neu protein for diagnosis of malignancies in which the HER-2/neu oncogene is associated
|
US5869445A
(en)
*
|
1993-03-17 |
1999-02-09 |
University Of Washington |
Methods for eliciting or enhancing reactivity to HER-2/neu protein
|
US6953573B1
(en)
|
1993-03-17 |
2005-10-11 |
University Of Washington |
Compounds for eliciting or enhancing immune reactivity to HER-2/neu protein for prevention or treatment of malignancies in which the HER-2/neu oncogene is associated
|
AU679008B2
(en)
*
|
1993-05-06 |
1997-06-19 |
Chiron Diagnostics Corporation |
Mixed luminescent conjugate test assays
|
AU2635295A
(en)
*
|
1994-06-13 |
1996-01-05 |
Henry Ford Health System |
A novel neuronal-neonatal gene: neuronatin
|
US5698686A
(en)
*
|
1994-10-20 |
1997-12-16 |
Arch Development Corporation |
Yeast telomerase compositions
|
US5843673A
(en)
*
|
1994-10-25 |
1998-12-01 |
Curators Of The University Of Missouri |
Method of screening for endometriosis
|
US6531277B2
(en)
|
1994-10-25 |
2003-03-11 |
The Curators Of The University Of Missouri |
Endometriosis-specific secretory protein
|
US20030152909A1
(en)
*
|
1994-11-16 |
2003-08-14 |
Mitrani Eduardo N. |
In vitro micro-organs, and uses related thereto
|
US5777093A
(en)
*
|
1995-05-16 |
1998-07-07 |
Ramot-University Authority For Applied Research & Industrial Development Ltd. |
cDNAs associated with ataxia-telangiectasia
|
US5858661A
(en)
|
1995-05-16 |
1999-01-12 |
Ramot-University Authority For Applied Research And Industrial Development |
Ataxia-telangiectasia gene and its genomic organization
|
US5728807A
(en)
*
|
1995-05-16 |
1998-03-17 |
Ramot-University Authority For Applied Research And Industrial Development, Ltd. |
Mutated proteins associated with ataxia-telangiectasia
|
US5807552A
(en)
*
|
1995-08-04 |
1998-09-15 |
Board Of Regents, The University Of Texas System |
Compositions for conferring immunogenicity to a substance and uses thereof
|
US6689757B1
(en)
|
1996-02-12 |
2004-02-10 |
M.L. Laboratories Plc |
Methods for vaccination and vaccines therefor
|
US6942862B2
(en)
*
|
1996-04-01 |
2005-09-13 |
University Of Washington |
Methods and compositions to generate immunity in humans against self tumor antigens by immunization with homologous foreign proteins
|
US6331275B1
(en)
|
1996-07-08 |
2001-12-18 |
Burstein Technologies, Inc. |
Spatially addressable, cleavable reflective signal elements, assay device and method
|
US20050069923A1
(en)
*
|
1996-07-08 |
2005-03-31 |
Mullis Kary Banks |
Dual bead assays using cleavable spacers and/or ligation to improve specificity and sensitivity including related methods and apparatus
|
AU725065B2
(en)
|
1996-07-08 |
2000-10-05 |
Burstein Technologies, Inc. |
Cleavable signal element device and method
|
US6342349B1
(en)
|
1996-07-08 |
2002-01-29 |
Burstein Technologies, Inc. |
Optical disk-based assay devices and methods
|
US20050214827A1
(en)
*
|
1996-07-08 |
2005-09-29 |
Burstein Technologies, Inc. |
Assay device and method
|
US5840322A
(en)
*
|
1996-12-19 |
1998-11-24 |
Ramot-University Authority For Applied Research & Industrial Devel. Ltd. |
Anti-oral-microbial adhesion fraction derived from vaccinium
|
WO1999009046A1
(fr)
*
|
1997-08-21 |
1999-02-25 |
Quark Biotech, Inc. |
Genes regules au niveau de l'hypoxemie
|
US6610838B1
(en)
|
1997-09-10 |
2003-08-26 |
Symbicom Aktiebolag |
P13 antigens from Borrelia
|
US6284496B1
(en)
|
1997-10-03 |
2001-09-04 |
University Of South Florida |
DNA vector for determining the presence of out-of-reading-frame mutations
|
AU748467B2
(en)
|
1997-10-17 |
2002-06-06 |
University Of South Florida |
Method to diagnose and monitor cellular immune deficiencies
|
US7687057B2
(en)
|
1998-01-09 |
2010-03-30 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
In vitro micro-organs, and uses related thereto
|
WO2000018885A1
(fr)
*
|
1998-09-29 |
2000-04-06 |
Gamida Cell Ltd. |
Procedes de regulation de la proliferation et de la differentiation de cellules souches et precurseurs
|
US20080206206A1
(en)
|
1998-05-07 |
2008-08-28 |
University Of South Florida |
Bone marrow-derived neuronal cells
|
US6344443B1
(en)
|
1998-07-08 |
2002-02-05 |
University Of South Florida |
Peptide antagonists of tumor necrosis factor alpha
|
WO2000002561A1
(fr)
|
1998-07-13 |
2000-01-20 |
University Of South Florida |
Modulation de la voie de phospholipase a2 utilisee comme procede therapeutique
|
EP1097378A2
(fr)
*
|
1998-07-21 |
2001-05-09 |
Burstein Laboratories Inc. |
Dispositifs de dosage utilisant des disques optiques et methodes correspondantes
|
CA2303855A1
(fr)
|
1998-07-22 |
2000-02-03 |
Jin Po Lee |
Dispositif permettant de deceler differents composants
|
US6187563B1
(en)
|
1998-08-07 |
2001-02-13 |
Yale University |
βIV-spectrin-polypeptides and nucleic acids encoding same
|
CN1230444C
(zh)
|
1998-11-16 |
2005-12-07 |
德克萨斯州立大学董事会 |
含有hiv细胞毒t淋巴细胞表位的hiv多肽或肽或其多聚核苷酸表达构建体的用途
|
ATE452181T1
(de)
|
1999-02-04 |
2010-01-15 |
Pluristem Ltd |
Verfahren und vorrichtung zur haltung und expansion von hematopoietischen stammzellen und/oder vorläuferzellen
|
US6440682B1
(en)
*
|
1999-05-28 |
2002-08-27 |
Detroit R&D Inc. |
Detection of hypertension using immunoreactive metabolic products
|
US6787318B1
(en)
|
1999-06-01 |
2004-09-07 |
Roskamp Research Institute, Llc |
Assay for evaluating the therapeutic effectiveness of agents in reducing Alzheimer's disease pathology
|
US7534605B2
(en)
|
1999-06-08 |
2009-05-19 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
CD44 polypeptides, polynucleotides encoding same, antibodies directed thereagainst and method of using same for diagnosing and treating inflammatory diseases
|
CN1420933A
(zh)
*
|
1999-06-25 |
2003-05-28 |
耶路撒冷希伯来大学伊森姆研究发展公司 |
应用微器官诱导血管生成的方法
|
US6875582B1
(en)
|
1999-08-19 |
2005-04-05 |
Omniscience Pharmaceuticals, Inc. |
Methods and targets of antibiotic resistance
|
US7101839B1
(en)
|
1999-08-30 |
2006-09-05 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Methods of and compositions for inhibiting the proliferation of mammalian cells
|
US7811981B2
(en)
*
|
1999-08-30 |
2010-10-12 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Methods of and compositions for inhibiting the proliferation of mammalian cells
|
US6998232B1
(en)
|
1999-09-27 |
2006-02-14 |
Quark Biotech, Inc. |
Methods of diagnosing bladder cancer
|
US7167615B1
(en)
|
1999-11-05 |
2007-01-23 |
Board Of Regents, The University Of Texas System |
Resonant waveguide-grating filters and sensors and methods for making and using same
|
AU784258B2
(en)
*
|
1999-11-19 |
2006-03-02 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Aspegillus niger beta-glucosidase gene, protein and uses thereof
|
US6544506B2
(en)
*
|
2000-01-05 |
2003-04-08 |
Yeda Research & Development Co. Ltd. |
Veto cells effective in preventing graft rejection and devoid of graft versus host potential
|
EP1252292A4
(fr)
*
|
2000-01-24 |
2004-11-17 |
Univ Ramot |
Plantes tolerant le stress de l'environnement, procedes d'elaboration pour ce type de plante et sequence polynucleotidique utilisee a cet effet
|
CA2404489A1
(fr)
|
2000-03-27 |
2001-10-04 |
Technion Research And Development Foundation Ltd. |
Complexes majeurs d'histocompatibilite monocatenaires de classe 1, constructions les codant et leurs methodes de production
|
US20040191260A1
(en)
|
2003-03-26 |
2004-09-30 |
Technion Research & Development Foundation Ltd. |
Compositions capable of specifically binding particular human antigen presenting molecule/pathogen-derived antigen complexes and uses thereof
|
IL135884A
(en)
*
|
2000-04-30 |
2005-08-31 |
Yissum Res Dev Co |
Method for measuring non-transferrin bound iron
|
HUP0300810A2
(hu)
|
2000-07-20 |
2003-08-28 |
M.G.V.S. Ltd. |
Mesterséges értranszplantátum, valamint ennek létrehozása és alkalmazása
|
US20040037828A1
(en)
|
2002-07-09 |
2004-02-26 |
Bar-Ilan University |
Methods and pharmaceutical compositions for healing wounds
|
US20030114410A1
(en)
|
2000-08-08 |
2003-06-19 |
Technion Research And Development Foundation Ltd. |
Pharmaceutical compositions and methods useful for modulating angiogenesis and inhibiting metastasis and tumor fibrosis
|
PT1315519E
(pt)
|
2000-08-08 |
2011-03-17 |
Technion Res & Dev Foundation |
Composições farmacêuticas e métodos úteis para tratamento de cancro e fibrose hepática
|
EP1683874A3
(fr)
|
2000-08-29 |
2006-10-11 |
YEDA RESEARCH AND DEVELOPMENT Co. LTD. |
Méthode pour l'isolement de gènes codant pour des protéines à fonction spécifique et pour le criblage d'agents pharmaceutiques actifs
|
US7632522B2
(en)
*
|
2000-09-28 |
2009-12-15 |
Nanocyte Inc. |
Use of stinging cells/capsules for the delivery of active agents to keratinous substances
|
IL155097A0
(en)
*
|
2000-09-28 |
2003-10-31 |
Nanocyte Inc |
Methods, compositions and devices utilizing stinging cells/capsules for delivering a therapeutic or a cosmetic agent into a tissue
|
US20070281037A9
(en)
*
|
2000-09-28 |
2007-12-06 |
Nanocyte Inc. |
Sterile preparations and compositions including stinging capsules and methods of producing and using same
|
EP1343894A4
(fr)
*
|
2000-11-02 |
2005-05-04 |
Univ Singapore |
Gene aopb, proteine, homologues, fragments et variants de celui-ci, ainsi que l'utilisation de ces derniers pour presentation a la surface cellulaire
|
MXPA03004325A
(es)
|
2000-11-17 |
2004-01-26 |
Vascular Biogenics Ltd |
Promotores que muestran especificidad celular endotelial y metodos para su uso.
|
US8071740B2
(en)
|
2000-11-17 |
2011-12-06 |
Vascular Biogenics Ltd. |
Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis
|
IL156015A0
(en)
|
2000-11-24 |
2003-12-23 |
Vascular Biogenics Ltd |
Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis
|
US20040248093A1
(en)
*
|
2000-11-27 |
2004-12-09 |
Coombs James Howard |
Magneto-optical bio-discs and systems including related methods
|
US20030003464A1
(en)
*
|
2000-11-27 |
2003-01-02 |
Phan Brigitte C. |
Dual bead assays including optical biodiscs and methods relating thereto
|
US20020172980A1
(en)
*
|
2000-11-27 |
2002-11-21 |
Phan Brigitte Chau |
Methods for decreasing non-specific binding of beads in dual bead assays including related optical biodiscs and disc drive systems
|
EP1337152A4
(fr)
*
|
2000-11-30 |
2004-08-11 |
Yeda Res & Dev |
Methodes d'utilisation de lymphocytes t mis en culture et n'induisant pas de reaction du greffon contre l'hote (gvhd) pour traiter des maladies
|
KR20030067696A
(ko)
|
2000-11-30 |
2003-08-14 |
모렉큐랄 스킨케어 리미티드 |
질병의 진단 및 치료
|
US20020142287A1
(en)
*
|
2000-12-14 |
2002-10-03 |
Hirotaka Yamamoto |
High throughput assay to detect inhibitors of the map kinase pathway
|
US7087395B1
(en)
|
2001-01-16 |
2006-08-08 |
Quest Diagnostics Investments Incorporated |
Vitamin D assay
|
US20050031618A1
(en)
*
|
2001-01-31 |
2005-02-10 |
Dror Mevorach |
Induction of tolerance by apoptotic and/or necrotic cells
|
US20050202098A1
(en)
*
|
2001-01-31 |
2005-09-15 |
Tolaren |
Disease therapy using dying or dead cells
|
US20030003454A1
(en)
|
2001-03-23 |
2003-01-02 |
Yeda Research And Development Co. Ltd. At The Weizmann Institute Of Science |
Methods and kits for determining a risk to develop cancer, for evaluating an effectiveness and dosage of cancer therapy and for correlating between an activity of a DNA repair enzyme and a cancer
|
EP1493014A2
(fr)
|
2001-04-11 |
2005-01-05 |
Burstein Technologies, Inc. |
Dosages a parametres multiples mettant en oeuvre des disques d'analyse, et procedes s'y rapportant
|
US6770622B2
(en)
|
2001-06-08 |
2004-08-03 |
Gary A. Jarvis |
N-terminally truncated galectin-3 for use in treating cancer
|
MXPA04000397A
(es)
*
|
2001-07-19 |
2004-03-18 |
Yissum Res Dev Co |
Polipeptidos que tienen actividad catalitica de isomerasa de carotenoides, acidos nucleicos que los codifican y usos de los mismos.
|
US7442781B2
(en)
|
2001-08-16 |
2008-10-28 |
Urifer Ltd. |
Diagnosis, prevention and treatment of cancer
|
US7138144B2
(en)
*
|
2001-09-07 |
2006-11-21 |
Nadir Askenasy |
Method of inducing immune tolerance via blood/lymph flow-restricted bone marrow transplantation
|
US20040136972A1
(en)
|
2001-09-07 |
2004-07-15 |
Yeda Research And Development Co. Ltd. |
Methods of treating disease by transplantation of developing allogeneic or xenogeneic organs or tissues
|
DE60237777D1
(de)
|
2001-10-19 |
2010-11-04 |
Vascular Biogenics Ltd |
Etzungen und verfahren zur gezielten herunterregulierung von angiogenese und zur krebstherapie
|
AUPR842501A0
(en)
*
|
2001-10-23 |
2001-11-15 |
Epipop Pty Ltd |
A method for identification and development of therapeutic agents
|
US6867005B2
(en)
|
2001-10-24 |
2005-03-15 |
Beckman Coulter, Inc. |
Method and apparatus for increasing the dynamic range and accuracy of binding assays
|
US6696254B2
(en)
|
2001-11-21 |
2004-02-24 |
Kimberly-Clark Worldwide, Inc. |
Detection and identification of enteric bacteria
|
WO2003048298A2
(fr)
*
|
2001-12-05 |
2003-06-12 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Nanoparticules contenant des homologues d'acides nucleiques polymeres, compositions pharmaceutiques et articles fabriques contenant ces nanoparticules, et procedes d'utilisation de celles-ci
|
US20050085432A1
(en)
*
|
2001-12-26 |
2005-04-21 |
Aviva Lapidot |
Methods of using conjugates of saccharides and acetamidino or guanidino compounds for treating bacterial infections
|
IL152904A0
(en)
*
|
2002-01-24 |
2003-06-24 |
Gamida Cell Ltd |
Utilization of retinoid and vitamin d receptor antagonists for expansion of renewable stem cell populations
|
WO2003062404A1
(fr)
*
|
2002-01-25 |
2003-07-31 |
Gamida-Cell Ltd. |
Methodes de developpement de cellules souches et de cellules precurseurs, populations de cellules multipliees obtenues a l'aide de ces methodes
|
US7781396B2
(en)
*
|
2002-01-31 |
2010-08-24 |
Tel Aviv University Future Technology Development L.P. |
Peptides directed for diagnosis and treatment of amyloid-associated disease
|
US20040052928A1
(en)
*
|
2002-09-06 |
2004-03-18 |
Ehud Gazit |
Peptides and methods using same for diagnosing and treating amyloid-associated diseases
|
US6992176B2
(en)
|
2002-02-13 |
2006-01-31 |
Technion Research & Development Foundation Ltd. |
Antibody having a T-cell receptor-like specificity, yet higher affinity, and the use of same in the detection and treatment of cancer, viral infection and autoimmune disease
|
WO2003070752A2
(fr)
*
|
2002-02-20 |
2003-08-28 |
Dyax Corporation |
Ligands de liaison au complexe mhc-peptide
|
DK2508596T3
(en)
|
2002-02-21 |
2015-10-19 |
Inst Virology |
MN / CA IX-specific monoclonal antibodies generated from MN / CA IX-poor mice, as well as methods of use.
|
AU2003214614B2
(en)
*
|
2002-03-18 |
2008-11-20 |
Gamida-Cell Ltd. |
Methods of inducing differentiation in ex vivo expanded stem cells
|
WO2003079967A2
(fr)
*
|
2002-03-26 |
2003-10-02 |
Nanocyte Inc. |
Cellules urticantes exprimant un polynucleotide exogene qui code pour un agent therapeutique, diagnostic ou cosmetique, et procedes, compositions et dispositifs faisant intervenir l'utilisation de ces cellules urticantes ou de capsules derivees de celles-ci pour administrer l'agent therapeutique, diagnostic ou cosmetique a
|
ATE437235T1
(de)
*
|
2002-04-16 |
2009-08-15 |
Univ California |
Verfahren zur prognose von nierenzellkarzinom und behandlungsauswahl mit carboanhydrase ix
|
US20040121442A1
(en)
*
|
2002-05-05 |
2004-06-24 |
Ilan Chet |
Fungal chitinase, polynucleotide sequences encoding same, promoters of same, and uses thereof
|
JP2005533102A
(ja)
*
|
2002-07-12 |
2005-11-04 |
イッサム リサーチ ディベロップメント カンパニー オブ ザ ヘブリュー ユニバーシティー オブ エルサレム |
微小器官によって生物学的プロセスを誘発する方法と装置
|
US7404951B2
(en)
|
2002-08-01 |
2008-07-29 |
Yeda Research And Development Co. Ltd. |
Method and composition for protecting neuronal tissue from damage induced by elevated glutamate levels
|
EP1573047B1
(fr)
|
2002-08-20 |
2013-11-13 |
OpSaniTx LLC |
Compositions de lectine et technique de modulation d'une reponse a un antigene
|
US7267981B2
(en)
|
2002-10-07 |
2007-09-11 |
Technion Research & Development Foundation Ltd. |
Human foreskin fibroblasts for culturing ES cells
|
WO2004037204A2
(fr)
*
|
2002-10-25 |
2004-05-06 |
University Of South Florida |
Methodes et composes de perturbation de la signalisation cd40r/cd40l dans le traitement de la maladie d'alzheimer
|
EP2295980A1
(fr)
|
2002-10-30 |
2011-03-16 |
Yissum Research Development Company, of The Hebrew University of Jerusalem |
Molécules et leurs procédés d'utilisation pour la mesure de fer non lié par la transferrine
|
US20050054097A1
(en)
*
|
2002-11-17 |
2005-03-10 |
Tony Peled |
EX-VIVO expansion of hematopoietic system cell populations in mononuclear cell cultures
|
US7947499B2
(en)
*
|
2002-11-29 |
2011-05-24 |
Technion Research & Development Foundation Ltd. |
Method of dynamically culturing embryonic stem cells
|
US7491699B2
(en)
*
|
2002-12-09 |
2009-02-17 |
Ramot At Tel Aviv University Ltd. |
Peptide nanostructures and methods of generating and using the same
|
DE60334846D1
(de)
|
2002-12-12 |
2010-12-16 |
R B T Rakuto Bio Technologies |
VERWENDUNG von LIGNINPEROXIDASE ZUR HAUT- UND HAARAUFHELLUNG
|
ES2705683T3
(es)
|
2002-12-16 |
2019-03-26 |
Technion Res & Dev Foundation |
Medio de cultivo de células madre pluripotentes
|
AU2003299872A1
(en)
|
2002-12-20 |
2004-07-22 |
Board Of Regents, The University Of Texas System |
Vmp-like sequences of pathogenic borrelia species and strains
|
JP2006512079A
(ja)
|
2003-01-02 |
2006-04-13 |
ラッパポート・ファミリー・インスティチュート・フォー・リサーチ・イン・ザ・メディカル・サイエンシズ |
高血糖性患者の心疾患を予防するための抗酸化治療の有効性を予測する方法
|
EP1583713B1
(fr)
*
|
2003-01-07 |
2009-03-25 |
Ramot at Tel Aviv University Ltd. |
Nanostructures de peptides encapsulant une matiere etrangere ainsi que procede de fabrication correspondant
|
US20050032126A1
(en)
*
|
2003-03-03 |
2005-02-10 |
Coombs James H. |
Methods and apparatus for use in detection and quantitation of various cell types and use of optical bio-disc for performing same
|
WO2004078991A2
(fr)
|
2003-03-04 |
2004-09-16 |
Yeda Research And Development Co. Ltd. |
Polypeptides pon, polynucleotides les codant et compositions et procedes utilisant ces derniers
|
AU2004217699B2
(en)
*
|
2003-03-07 |
2008-07-03 |
Gamida-Cell Ltd. |
Expansion of renewable stem cell populations using modulators of PI 3-kinase
|
US8017113B2
(en)
|
2003-03-12 |
2011-09-13 |
Rappaport Family Institute For Research In The Medical Sciences |
Compositions and methods for diagnosing and treating an inflammation
|
US7294701B2
(en)
*
|
2003-04-02 |
2007-11-13 |
Technion Research & Development Foundation Ltd. |
Antibody fragment capable of modulating multidrug resistance and compositions and kits and methods using same
|
WO2004087042A2
(fr)
|
2003-04-04 |
2004-10-14 |
Yeda Research And Development Co. Ltd. |
Anticorps et compositions pharmaceutiques contenant ces derniers utiles pour inhiber l'activite de metalloproteines
|
US8252588B2
(en)
|
2003-04-08 |
2012-08-28 |
Yeda Research And Development Co. Ltd. |
Stem cells having increased sensitivity to SDF-1 and methods of generating and using same
|
FR2853551B1
(fr)
|
2003-04-09 |
2006-08-04 |
Lab Francais Du Fractionnement |
Formulation stabilisante pour compositions d'immunoglobulines g sous forme liquide et sous forme lyophilisee
|
US7321065B2
(en)
*
|
2003-04-18 |
2008-01-22 |
The Regents Of The University Of California |
Thyronamine derivatives and analogs and methods of use thereof
|
WO2005035556A2
(fr)
*
|
2003-05-06 |
2005-04-21 |
Iguazu Biosciences Corp. |
Particules pseudo-virales du coronavirus du sras et methodes d'utilisation
|
CA2978152C
(fr)
|
2003-05-22 |
2021-01-26 |
Evogene Ltd. |
Procedes d'augmentation de la tolerance du stress abiotique des plantes et plantes ainsi produites
|
US7554007B2
(en)
*
|
2003-05-22 |
2009-06-30 |
Evogene Ltd. |
Methods of increasing abiotic stress tolerance and/or biomass in plants
|
AU2005234725B2
(en)
|
2003-05-22 |
2012-02-23 |
Evogene Ltd. |
Methods of Increasing Abiotic Stress Tolerance and/or Biomass in Plants and Plants Generated Thereby
|
EP1635765B1
(fr)
|
2003-05-23 |
2013-07-17 |
Board Of Regents, The University Of Texas System |
Oligonucleoside phosphorothioate selectionnes de maniere combinatoire et a base structurelle et facteurs de transcription ap-1 ciblant un phosphorodithioate aptamere
|
US20050020499A1
(en)
*
|
2003-05-27 |
2005-01-27 |
Bar Ilan University |
Methods of attenuating cocaine seeking behavior employing glial cell-derived neurotrophic factor (GDNF) and pharmaceutical compositions and articles of manufacture suited for use in practice of the method
|
US7498428B2
(en)
*
|
2003-06-19 |
2009-03-03 |
Evogene Ltd. |
Nucleotide sequences for regulating gene expression in plant trichomes and constructs and methods utilizing same
|
US8129514B2
(en)
*
|
2003-06-19 |
2012-03-06 |
Evogene Ltd. |
Nucleotide sequences for regulating gene expression in plant trichomes and constructs and methods utilizing same
|
EP2719394B1
(fr)
|
2003-06-30 |
2015-07-29 |
Tel Aviv University Future Technology Development L.P. |
Peptides pour traiter des maladies associées aux amyloïdes
|
AU2004257645A1
(en)
*
|
2003-07-07 |
2005-01-27 |
David H. Wagner |
Methods for predicting development of auto-immune diseases and treatment of same
|
WO2005019417A2
(fr)
*
|
2003-08-14 |
2005-03-03 |
The Bio Balance Corporation |
Souches bacteriennes, compositions les comprenant et leur utilisation dans un traitement probiotique
|
US7625707B2
(en)
|
2003-10-02 |
2009-12-01 |
Ramot At Tel Aviv University Ltd. |
Antibacterial agents and methods of identifying and utilizing same
|
IL158287A0
(en)
|
2003-10-07 |
2004-05-12 |
Yeda Res & Dev |
Antibodies to nik, their preparation and use
|
ATE509034T1
(de)
|
2003-10-07 |
2011-05-15 |
Yeda Res & Dev |
Antikörper gegen nik, deren herstellung und verwendung
|
CA2542221A1
(fr)
*
|
2003-10-23 |
2005-05-06 |
Pfizer Products Inc. |
Vaccin contre les parodontopathies
|
PL1684805T3
(pl)
|
2003-11-04 |
2010-12-31 |
Novartis Vaccines & Diagnostics Inc |
Sposoby leczenia szpiczaka mnogiego z zastosowaniem antagonistycznych monoklonalnych przeciwciał przeciwko CD40
|
PT1680141E
(pt)
|
2003-11-04 |
2010-12-20 |
Novartis Vaccines & Diagnostic |
Métodos terapêuticos para tumores sólidos que expressam o antigénio de superfície celular cd40
|
PL1682177T3
(pl)
|
2003-11-04 |
2011-03-31 |
Novartis Vaccines & Diagnostics Inc |
Zastosowanie antagonistycznych przeciwciał anty-CD40 do leczenia przewlekłej białaczki limfocytowej
|
EP2248830A1
(fr)
|
2003-11-04 |
2010-11-10 |
Novartis Vaccines and Diagnostics, Inc. |
Utilisation d'anticorps antagonistes anti-CD40 pour le traitement de maladies autoimmunes et inflammatoires et le rejet d'organes transplantés
|
JP5039383B2
(ja)
|
2003-11-30 |
2012-10-03 |
イエダ リサーチ アンド ディベロップメント カンパニー リミテッド |
免疫モジュレーションのための方法および薬剤ならびに免疫モジュレーターの同定方法
|
WO2005059100A2
(fr)
*
|
2003-12-12 |
2005-06-30 |
New York University |
Procedes et compositions se rapportant a la cystatine c
|
US20100221233A1
(en)
*
|
2003-12-15 |
2010-09-02 |
University Of South Florida |
Compositions and methods for enhancing neuroprotection via administration of stem cells and blood brain barrier permeabilizers
|
EP1722834B1
(fr)
|
2003-12-22 |
2012-06-27 |
Regentis Biomaterials Ltd. |
Matrice comprenant un squelette proteique reticule naturel
|
US8007847B2
(en)
*
|
2004-01-13 |
2011-08-30 |
Eytan Biderman |
Feeding formula appliance
|
US7423139B2
(en)
*
|
2004-01-20 |
2008-09-09 |
Insight Biopharmaceuticals Ltd. |
High level expression of recombinant human erythropoietin having a modified 5′-UTR
|
WO2005071058A2
(fr)
*
|
2004-01-27 |
2005-08-04 |
Compugen Ltd. |
Procedes et systemes pour l'annotation de sequences de biomolecules
|
JP2007526337A
(ja)
|
2004-03-02 |
2007-09-13 |
アクセルロン ファーマ インコーポレーテッド |
Alk7およびミオスタチン阻害剤ならびにその使用
|
US8352031B2
(en)
|
2004-03-10 |
2013-01-08 |
Impulse Dynamics Nv |
Protein activity modification
|
US7812218B2
(en)
|
2004-06-14 |
2010-10-12 |
Evogene Ltd. |
Polynucleotides and polypeptides involved in plant fiber development and methods of using same
|
US8680062B2
(en)
*
|
2004-07-06 |
2014-03-25 |
Deliversir Ltd. |
System for delivering therapeutic agents into living cells and cells nuclei
|
WO2006006172A2
(fr)
*
|
2004-07-15 |
2006-01-19 |
Ramot At Tel Aviv University Ltd. |
Utilisation d'agents anti-amyloides pour traiter et determiner des infections pathogenes
|
EP2295974A1
(fr)
|
2004-09-08 |
2011-03-16 |
THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES |
Compositions et procédés pour la détection d'une infection par VIH-1/VIH-2
|
EP1799812A4
(fr)
*
|
2004-09-16 |
2009-09-09 |
Gamida Cell Ltd |
Méthodes de culture ex vivo de cellules souches et de précurseur par co-culture avec des cellules mésenchymales
|
US20060095241A1
(en)
*
|
2004-10-29 |
2006-05-04 |
Microsoft Corporation |
Systems and methods that utilize machine learning algorithms to facilitate assembly of aids vaccine cocktails
|
US8000900B2
(en)
|
2004-09-21 |
2011-08-16 |
Microsoft Corporation |
Association-based predictions of pathogen characteristics
|
EP1805319B1
(fr)
*
|
2004-09-29 |
2014-09-03 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Rnase t2 humaine recombinee et utilisations associees
|
WO2006035442A2
(fr)
|
2004-09-29 |
2006-04-06 |
Collplant Ltd. |
Collagene de recombinaison produit dans une plante
|
US7781402B2
(en)
*
|
2004-10-12 |
2010-08-24 |
Closed Loop Therapies Ltd. |
Methods and implantable devices for treating supraventricular arrhythmias
|
US8478535B2
(en)
|
2004-10-29 |
2013-07-02 |
Microsoft Corporation |
Systems and methods that utilize machine learning algorithms to facilitate assembly of aids vaccine cocktails
|
US20090118132A1
(en)
*
|
2004-11-04 |
2009-05-07 |
Roche Molecular Systems, Inc. |
Classification of Acute Myeloid Leukemia
|
US7842794B2
(en)
|
2004-12-17 |
2010-11-30 |
Roche Molecular Systems, Inc. |
Reagents and methods for detecting Neisseria gonorrhoeae
|
US20060134680A1
(en)
*
|
2004-12-22 |
2006-06-22 |
Alexander Kotlyar |
Homogeneous populations of nucleic acids, methods of synthesyzing same and uses thereof
|
WO2006075334A2
(fr)
*
|
2005-01-16 |
2006-07-20 |
Zlango Ltd. |
Communication iconique
|
JP2008529325A
(ja)
*
|
2005-01-16 |
2008-07-31 |
ズランゴー リミテッド |
通信ネットワークシステムおよびそれを使用するための方法
|
US8019818B2
(en)
*
|
2005-01-18 |
2011-09-13 |
Zlango Ltd. |
Communications network system and methods for using same
|
EP3028765B1
(fr)
|
2005-01-31 |
2020-01-08 |
Realbio Technologies Ltd. |
Méthode de transfert séquentiel de liquides à travers un dispositif capillaire a flux lateral
|
AU2006215300C9
(en)
|
2005-02-17 |
2010-05-06 |
Hadasit Medical Research Services And Development Ltd. |
Bisphosphonates for treating endometriosis
|
US8216801B2
(en)
|
2005-02-25 |
2012-07-10 |
The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization, (A.R.O.), The Volcani Center |
Methods for treating inflammatory disorders
|
US7695927B2
(en)
*
|
2005-03-18 |
2010-04-13 |
Detroit R & D |
Detection of hypertension using glucuronidated metabolic products
|
WO2006109312A2
(fr)
*
|
2005-04-15 |
2006-10-19 |
Vascular Biogenics Ltd. |
Compositions contenant des peptides derives de la glycoproteine i beta 2 pour la prevention et le traitement de maladie cardiovasculaire
|
US8834862B2
(en)
*
|
2005-04-19 |
2014-09-16 |
Nanocyte Inc. |
Methods, compositions and devices utilizing stinging cells/capsules for conditioning a tissue prior to delivery of an active agent
|
AU2006247134B2
(en)
|
2005-05-18 |
2012-05-10 |
Novartis Ag |
Methods for diagnosis and treatment of diseases having an autoimmune and/or inflammatory component
|
EP2279726A3
(fr)
|
2005-05-26 |
2012-06-20 |
Biorest Ltd. |
Compositions et méthodes d'utilisation desdites compositions dans l'administration d'agents dans un organe cible protégé par une barrière sanguine
|
WO2006134602A2
(fr)
|
2005-06-16 |
2006-12-21 |
Ramot At Tel Aviv University Ltd. |
Cellules isolees et populations comprenant ces cellules pour le traitement de maladies du snc
|
US20070225242A1
(en)
*
|
2005-06-21 |
2007-09-27 |
The Board Of Trustees Of The Leland Stanford Junior University |
Method and composition for treating and preventing tumor metastasis in vivo
|
US20060292559A1
(en)
*
|
2005-06-23 |
2006-12-28 |
Beckman Coulter, Inc. |
Cell-based microarrays, and methods for their preparation and use
|
JP5383186B2
(ja)
*
|
2005-07-07 |
2014-01-08 |
イッサム リサーチ ディベロプメント カンパニー オブ ザ ヘブリュー ユニバーシティ オブ エルサレム リミテッド |
H19をダウンレギュレートする核酸薬剤、及びそれを使用する方法
|
JP5086254B2
(ja)
|
2005-07-07 |
2012-11-28 |
フルクルム エスピー リミテッド |
Sp1ポリペプチド、変性sp1ポリペプチドおよびそれらの使用
|
CA2615218A1
(fr)
|
2005-07-18 |
2007-01-25 |
Protalix Ltd. |
Administration mucosale ou enterale de macromolecules biologiquement actives
|
US7993657B2
(en)
|
2005-07-26 |
2011-08-09 |
University Of Medicine And Dentistry Of New Jersey |
Antibody profiles characteristic of tuberculosis state
|
AU2006278260B2
(en)
*
|
2005-08-08 |
2012-03-08 |
Onconon, Llc. |
Antibody compositions, methods for treating neoplastic disease and methods for regulating fertility
|
EP2514315A3
(fr)
|
2005-08-24 |
2012-11-07 |
Yeda Research and Development Co. Ltd. |
Cellules tolerogeniques derivees de donneurs universels et destinees a induire une tolerance a la transplantation non syngenique
|
EP1962719A4
(fr)
|
2005-08-29 |
2011-05-04 |
Technion Res And Dev Of Foundation Ltd |
Milieux de culture de cellules souches
|
WO2007034487A1
(fr)
|
2005-09-22 |
2007-03-29 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Constructions d’acide nucléique, compositions pharmaceutiques et procédés utilisant ces dernières dans le cadre des traitements anticancéreux
|
US20070087437A1
(en)
*
|
2005-10-14 |
2007-04-19 |
Jifan Hu |
Methods for rejuvenating cells in vitro and in vivo
|
MX350551B
(es)
|
2005-10-24 |
2017-09-08 |
Evogene Ltd |
Polipeptidos aislados, polinucleotidos que los codifican, plantas transgenicas que expresan los mismos y metodos para usarlos.
|
US8846393B2
(en)
|
2005-11-29 |
2014-09-30 |
Gamida-Cell Ltd. |
Methods of improving stem cell homing and engraftment
|
WO2007063545A2
(fr)
|
2005-11-29 |
2007-06-07 |
Gamida-Cell Ltd. |
Methodes d'amelioration de prise de greffe et de nostocytose de cellules souches
|
US8775526B2
(en)
|
2006-01-16 |
2014-07-08 |
Zlango Ltd. |
Iconic communication
|
EP2368569A3
(fr)
|
2006-01-18 |
2012-05-02 |
University Of Chicago |
Compositions et procédés liés aux protéines des bactéries staphylocoques
|
US10351615B2
(en)
|
2006-02-03 |
2019-07-16 |
Opko Biologics Ltd. |
Methods of treatment with long-acting growth hormone
|
US8048849B2
(en)
|
2006-02-03 |
2011-11-01 |
Modigene, Inc. |
Long-acting polypeptides and methods of producing same
|
US8450269B2
(en)
|
2006-02-03 |
2013-05-28 |
Prolor Biotech Ltd. |
Long-acting growth hormone and methods of producing same
|
US20150038413A1
(en)
|
2006-02-03 |
2015-02-05 |
Opko Biologics Ltd. |
Long-acting polypeptides and methods of producing and administering same
|
US7553941B2
(en)
*
|
2006-02-03 |
2009-06-30 |
Modigene Inc |
Long-acting polypeptides and methods of producing same
|
US20140113860A1
(en)
|
2006-02-03 |
2014-04-24 |
Prolor Biotech Ltd. |
Long-acting polypeptides and methods of producing and administering same
|
US9249407B2
(en)
|
2006-02-03 |
2016-02-02 |
Opko Biologics Ltd. |
Long-acting coagulation factors and methods of producing same
|
US9458444B2
(en)
|
2006-02-03 |
2016-10-04 |
Opko Biologics Ltd. |
Long-acting coagulation factors and methods of producing same
|
US8759292B2
(en)
|
2006-02-03 |
2014-06-24 |
Prolor Biotech, Llc |
Long-acting coagulation factors and methods of producing same
|
US8048848B2
(en)
|
2006-02-03 |
2011-11-01 |
Prolor Biotech Ltd. |
Long-acting interferons and derivatives thereof and methods thereof
|
US10221228B2
(en)
|
2006-02-03 |
2019-03-05 |
Opko Biologics Ltd. |
Long-acting polypeptides and methods of producing and administering same
|
US8946155B2
(en)
|
2006-02-03 |
2015-02-03 |
Opko Biologics Ltd. |
Long-acting polypeptides and methods of producing and administering same
|
US8476234B2
(en)
|
2006-02-03 |
2013-07-02 |
Prolor Biotech Inc. |
Long-acting coagulation factors and methods of producing same
|
BRPI0706967A2
(pt)
|
2006-02-06 |
2011-04-12 |
Rappaport Family Inst For Res |
método e kit para diagnosticar dmt1
|
EP1991852B1
(fr)
|
2006-03-06 |
2015-07-01 |
Zetiq Technologies Ltd. |
Procédés pour identifier un phénotype cellulaire
|
EP2548951B1
(fr)
|
2006-03-23 |
2016-05-04 |
Pluristem Ltd. |
Procédés de développement cellulaire et utilisations thérapeutiques des cellules et des milieux conditionnés produits de cette manière
|
EP2004858A4
(fr)
|
2006-03-28 |
2009-12-09 |
Tel Hashomer Medical Res Infrastructure & Services Ltd |
Procedes et kits pour determiner la predisposition a la resistance a la warfarine
|
KR20090029184A
(ko)
*
|
2006-04-07 |
2009-03-20 |
더 가브먼트 오브 더 유나이티드 스테이츠 오브 아메리카, 리프리젠티드 바이 더 세크러테리, 디파트먼트 오브 헬쓰 앤드 휴먼 서비씨즈 |
항체 조성물 및 신생물성 질병의 치료 방법
|
KR101317235B1
(ko)
|
2006-04-21 |
2013-10-15 |
조마 테크놀로지 리미티드 |
길항제 항-cd40 항체 제약 조성물
|
KR101442209B1
(ko)
*
|
2006-05-19 |
2014-11-18 |
테크니온 리서치 엔드 디벨로프먼트 화운데이션 엘티디. |
융합 단백질, 이의 용도 및 이의 제조방법
|
US20070281883A1
(en)
*
|
2006-06-05 |
2007-12-06 |
Hanna Rosenfeld |
Development of follicle stimulating hormone agonists and antagonists in fish
|
WO2008010228A2
(fr)
|
2006-07-20 |
2008-01-24 |
Yeda Research And Development Co. Ltd. |
Organismes photosynthétiques, compositions et procédés de génération desdits organismes
|
US8809052B2
(en)
|
2006-08-28 |
2014-08-19 |
Yeda Research And Development Co. Ltd. |
Methods of generating mature oligodendrocytes
|
US20080138840A1
(en)
*
|
2006-09-08 |
2008-06-12 |
Collins Michael T |
Assay for antibodies to mycobacterium paratuberculosis
|
WO2008041183A2
(fr)
|
2006-10-05 |
2008-04-10 |
Technion Research & Development Foundation Ltd. |
Microtubes et leurs procédés de fabrication
|
US7888059B2
(en)
*
|
2006-10-05 |
2011-02-15 |
Yeda Research And Development Co. Ltd. |
Highly purified and stabilized Na,K-ATPase isoforms and methods of producing same
|
CA2672756C
(fr)
*
|
2006-12-20 |
2018-11-20 |
Evogene Ltd. |
Polynucleotides et polypeptides impliques dans le developpement de fibres vegetales et procedes d'utilisation
|
GB0700133D0
(en)
|
2007-01-04 |
2007-02-14 |
Humabs Llc |
Human cytomegalovirus neutralising antibodies and use thereof
|
US20100086526A1
(en)
*
|
2007-01-16 |
2010-04-08 |
Abraham Hochberg |
Nucleic acid constructs and methods for specific silencing of h19
|
WO2008093331A1
(fr)
*
|
2007-01-29 |
2008-08-07 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Conjugues d'anticorps pour vaincre la multiresistances aux medicaments
|
US8911996B2
(en)
|
2007-01-31 |
2014-12-16 |
Technion Research & Development Foundation Limited |
Electrospun scaffolds and methods of generating and using same
|
EP2125050B1
(fr)
|
2007-02-01 |
2014-07-30 |
Technion Research & Development Foundation Ltd. |
Fibres et tissus d'albumine et leurs procédés de génération et d'utilisation
|
AU2008214077B2
(en)
|
2007-02-02 |
2012-12-13 |
Baylor Research Institute |
Multivariable antigens complexed with targeting humanized monoclonal antibody
|
NZ578696A
(en)
|
2007-02-02 |
2012-01-12 |
Baylor Res Inst |
Vaccines based on targeting antigen to dcir expressed an antigen-presenting cells
|
TWI422594B
(zh)
|
2007-02-02 |
2014-01-11 |
Baylor Res Inst |
經由樹狀細胞去唾液酸糖蛋白受體(dc-asgpr)接合抗原呈現細胞之藥劑
|
EP3489260B1
(fr)
*
|
2007-02-23 |
2020-12-02 |
Baylor Research Institute |
Activation de cellules humaines présentant un antigène par l'intermédiaire du récepteur ldl 1 oxyde de type lectine (lox-1) de cellules dendritiques
|
NZ710459A
(en)
*
|
2007-02-23 |
2016-06-24 |
Baylor Res Inst |
Therapeutic applications of activation of human antigen-presenting cells through dectin-1
|
TW200900078A
(en)
*
|
2007-02-23 |
2009-01-01 |
Baylor Res Inst |
Activation of human antigen-presenting cells through CLEC-6
|
ES2662036T3
(es)
|
2007-02-28 |
2018-04-05 |
Yeda Research And Development Company Limited |
Secuencias que se dirigen al núcleo
|
EP2514766A3
(fr)
|
2007-03-29 |
2013-06-05 |
Technion Research & Development Foundation Ltd. |
Anticorps, procédés et kits pour diagnostiquer et traiter un mélanome
|
KR20100015774A
(ko)
|
2007-04-02 |
2010-02-12 |
라모트 앳 텔-아비브 유니버시티 리미티드 |
암세포 검출 방법 및 그 질병의 진단 및 그 질병의 치료의 모니터링을 위한 상기 방법의 용도
|
CA2683143C
(fr)
*
|
2007-04-09 |
2018-06-12 |
Evogene Ltd. |
Polynucleotides, polypeptides et procedes permettant d'augmenter la teneur en huile, la vitesse de croissance et la biomasse de plantes
|
US9156865B2
(en)
|
2007-04-23 |
2015-10-13 |
Deliversir Ltd |
System for delivering therapeutic agents into living cells and cells nuclei
|
PL2144633T4
(pl)
*
|
2007-04-23 |
2015-02-27 |
Sabag Rfa Ltd |
Układ do transportu czynników terapeutycznych do żywych komórek i jąder komórkowych
|
US9556210B2
(en)
|
2007-04-23 |
2017-01-31 |
Sabag-Rfa Ltd. |
System for delivering therapeutic agents into living cells and cells nuclei
|
ES2564312T3
(es)
|
2007-05-01 |
2016-03-21 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Métodos y kits para detectar células fetales en la sangre materna
|
CN107098970B
(zh)
|
2007-05-03 |
2021-11-23 |
新加坡科技研究局 |
结合细胞内prl-1多肽或prl-3多肽的抗体
|
SI2150608T1
(en)
|
2007-05-07 |
2018-04-30 |
Protalix Ltd. |
An extensive disposable bioreactor
|
US20100197767A1
(en)
|
2007-07-11 |
2010-08-05 |
Lior Nissim |
Nucleic acid construct systems capable of daignosing or treating a cell state
|
AU2008277257B2
(en)
|
2007-07-15 |
2014-03-06 |
Hillman, Yitzchak Mr |
Disease treatment via antimicrobial peptides or their inhibitors
|
IL184627A0
(en)
|
2007-07-15 |
2008-12-29 |
Technion Res & Dev Foundation |
Agents for diagnosing and modulating metastasis and fibrosis as well as inflammation in a mammalian tissue
|
ES2547305T3
(es)
|
2007-07-24 |
2015-10-05 |
Evogene Ltd. |
Polinucleótidos, polipéptidos codificados por los mismos, y métodos de uso de los mismos para aumentar la tolerancia al estrés abiótico y/o la biomasa y/o el rendimiento en plantas que los expresan
|
JP5659014B2
(ja)
*
|
2007-08-02 |
2015-01-28 |
ジリード バイオロジクス,インク. |
線維症、腫瘍浸潤、血管新生及び転移の治療及び診断のための方法及び組成物
|
ES2406105T3
(es)
|
2007-08-15 |
2013-06-05 |
Yeda Research And Development Co. Ltd. |
Reguladores de la MMP-9 y usos de los mismos
|
US20090068669A1
(en)
*
|
2007-09-12 |
2009-03-12 |
Elias Georges |
Slc9a3r1 directed diagnostics for neoplastic disease
|
WO2009034574A2
(fr)
|
2007-09-12 |
2009-03-19 |
Yeda Research And Development Co. Ltd. |
Procédés de traitement de tumeurs dans des sites privilégiés immunitairement
|
EP2200622B2
(fr)
|
2007-09-19 |
2015-07-29 |
Pluristem Ltd. |
Cellules adhérentes provenant de tissus adipeux ou placentaires et leur utilisation thérapeutique
|
ES2620487T3
(es)
|
2007-10-19 |
2017-06-28 |
Rappaport Family Institute For Research In The Medical Sciences |
Composiciones que comprenden semaforinas para uso en el tratamiento del cáncer
|
WO2009059328A2
(fr)
*
|
2007-11-02 |
2009-05-07 |
The Johns Hopkins University |
Vaccin l2 multicomposant pour la prévention d'une infection de papillomavirus humain
|
WO2009069123A2
(fr)
|
2007-11-26 |
2009-06-04 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Compositions renfermant des polypeptides fibreux et des polysaccharides
|
CA2709517C
(fr)
|
2007-12-27 |
2019-02-26 |
Evogene Ltd. |
Polypeptides isoles, polynucleotides utiles pour modifier l'efficacite de l'utilisation de l'eau, l'efficacite de l'utilisation de fertilisant, la tolerance au stress biotique/abiotique, le rendement et la biomasse chez les plantes
|
US20090233295A1
(en)
*
|
2008-01-29 |
2009-09-17 |
Elias Georges |
Trim59 directed diagnostics for neoplastic disease
|
CA2713667A1
(fr)
*
|
2008-01-31 |
2009-08-06 |
Compugen Ltd. |
Isoforme cd55 et ses utilisations pour la detection du cancer, la surveillance du cancer et la therapie contre le cancer
|
WO2009104174A2
(fr)
|
2008-02-21 |
2009-08-27 |
Technion Research & Development Foundation Ltd . |
Procédé pour fixer sur un microtube une cellule étudiée
|
EP2265955A1
(fr)
*
|
2008-03-18 |
2010-12-29 |
Wisconsin Alumni Research Foundation |
Essai de criblage pour les mycobactéries en culture à base du complexe Mycobactérium avium
|
EP2280731A1
(fr)
*
|
2008-04-09 |
2011-02-09 |
Technion Research and Development Foundation, Ltd. |
Anticorps anti-immunodéficience humaine et leurs utilisations
|
EP2297200A1
(fr)
*
|
2008-04-09 |
2011-03-23 |
Technion Research & Development Foundation Ltd. |
Anticorps antigrippe et leurs utilisations
|
EP2508325A3
(fr)
*
|
2008-04-10 |
2013-05-22 |
Objet Ltd. |
Système et procédé pour l' impression de modèles en trois dimensions
|
EP3020410A1
(fr)
|
2008-04-18 |
2016-05-18 |
Collplant Ltd. |
Procédés de génération et d'utilisation de procollagène
|
WO2009130695A2
(fr)
|
2008-04-21 |
2009-10-29 |
Danziger Innovation Ltd. |
Vecteurs d'expression de virus végétaux et leur utilisation pour générer des variations génotypiques dans des génomes de plantes
|
JP2010043063A
(ja)
|
2008-05-09 |
2010-02-25 |
Agency For Science Technology & Research |
川崎病の診断及び治療
|
BR122020021867B1
(pt)
*
|
2008-05-22 |
2021-05-11 |
Evogene Ltd |
método de aumento do rendimento, da taxa de crescimento, da biomassa, do vigor, da tolerância ao estresse abiótico e/ou da eficiência no uso do nitrogênio de uma planta, e, construção de ácido nucléico
|
WO2009144720A1
(fr)
|
2008-05-27 |
2009-12-03 |
Pluristem Ltd. |
Procédés de traitement de maladies inflammatoires du côlon
|
EP3514229A1
(fr)
|
2008-05-28 |
2019-07-24 |
Ramot at Tel-Aviv University Ltd. |
Cellules souches mésenchymateuses destinées au traitement de troubles du snc
|
US9952211B2
(en)
|
2008-06-29 |
2018-04-24 |
Realbio Technologies Ltd. |
Liquid-transfer device particularly useful as a capturing device in a biological assay process
|
EP2303923B1
(fr)
|
2008-07-16 |
2015-06-24 |
Institute for Research in Biomedicine |
Anticorps neutralisant les cytomégalovirus humains et leur utilisation
|
ES2682596T3
(es)
|
2008-07-16 |
2018-09-21 |
Institute For Research In Biomedicine |
Anticuerpos neutralizantes del citomegalovirus humano y uso de los mismos
|
EP2966091B1
(fr)
|
2008-07-16 |
2018-04-25 |
Baylor Research Institute |
Anticorps agonistes anti-cd40
|
JP5607620B2
(ja)
*
|
2008-07-25 |
2014-10-15 |
インスティテュート・フォー・リサーチ・イン・バイオメディシン |
抗a型インフルエンザウイルス中和抗体およびその使用
|
US8871207B2
(en)
|
2008-07-25 |
2014-10-28 |
Humabs, LLC |
Neutralizing anti-influenza A virus antibodies and uses thereof
|
WO2010016806A1
(fr)
|
2008-08-08 |
2010-02-11 |
Agency For Science, Technology And Research (A*Star) |
Vhz pour le diagnostic et le traitement de cancers
|
EP2657342B1
(fr)
|
2008-08-08 |
2015-11-18 |
Genisphere, LLC |
Dendrimères d'ADN protégés contre la dégradation par les nucléases
|
BRPI0912898B1
(pt)
|
2008-08-18 |
2022-04-12 |
Evogene Ltd |
Método para aumentar a eficiência de uso do nitrogênio e/ou tolerância à deficiência de nitrogênio de uma planta
|
RU2539786C2
(ru)
|
2008-09-02 |
2015-01-27 |
Плуристем Лтд. |
Выращенные в прикрепленной к субстрату культуре клетки из ткани плаценты и их использование при лечении
|
US8367392B2
(en)
*
|
2008-09-05 |
2013-02-05 |
Transalgae Ltd. |
Genetic transformation of algal and cyanobacteria cells by microporation
|
EP2326340A4
(fr)
|
2008-09-11 |
2013-01-23 |
Univ Ben Gurion |
Compositions et procédés destinés à traiter une infection par s. pneumoniae
|
CN107595889A
(zh)
|
2008-09-12 |
2018-01-19 |
克里奥普拉斯低温生物有限公司 |
缺血性组织的细胞疗法
|
EP3670524A1
(fr)
|
2008-09-24 |
2020-06-24 |
Tel HaShomer Medical Research Infrastructure and Services Ltd. |
Peptides et compositions pour la prévention de l'adhésion cellulaire et leurs procédés d'utilisation
|
CA2736729A1
(fr)
|
2008-09-29 |
2010-04-01 |
Ben Gurion University Of The Negev Research And Development Authority |
Beta-peptides amyloides et procedes d'utilisation associes
|
BRPI0920041A2
(pt)
|
2008-10-06 |
2017-06-27 |
Univ Chicago |
composições e processos relacionados às proteínas eap, emp e/ou adsa bacterianas
|
US8921658B2
(en)
*
|
2008-10-30 |
2014-12-30 |
Evogene Ltd. |
Isolated polynucleotides encoding a MAP65 polypeptide and methods of using same for increasing plant yield
|
US20110229892A1
(en)
|
2008-11-17 |
2011-09-22 |
Yehuda G Assaraf |
Method for predicting a patient's responsiveness to anti-folate therapy
|
WO2010058396A1
(fr)
|
2008-11-19 |
2010-05-27 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Anticorps anti-cd44vra et procédés diagnostiques et thérapeutiques l'utilisant
|
WO2010061383A1
(fr)
|
2008-11-26 |
2010-06-03 |
Biodalia Microbiological Technologies Ltd. |
Procédé permettant d’enrichir in-situ des aliments avec des fructanes
|
WO2010064231A1
(fr)
|
2008-12-02 |
2010-06-10 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Procédés d’analyse d’édition d’arn a-i et constructions d’acide nucléique capables de ceux-ci
|
WO2010064247A1
(fr)
|
2008-12-03 |
2010-06-10 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Procédés et trousses pour déterminer une prédisposition au cancer
|
US8734759B2
(en)
|
2008-12-05 |
2014-05-27 |
Yeda Research And Development Co. Ltd. |
Methods of diagnosing and treating motor neuron diseases
|
WO2010071610A1
(fr)
|
2008-12-19 |
2010-06-24 |
Agency For Science, Technology And Research (A*Star) |
Marqueurs biologiques de chikungunya sévère
|
WO2010076788A2
(fr)
|
2008-12-29 |
2010-07-08 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Méthodes de prédiction de la réponse au traitement par un interféron et traitement d'une infection par l'hépatite c
|
WO2010076756A2
(fr)
|
2008-12-29 |
2010-07-08 |
Evogene Ltd. |
Polynucleotides, polypeptides codes par ceux-ci, et leurs procedes d'utilisation pour augmenter la tolerance au stress abiotique, la biomasse et/ou le rendement dans les plantes les exprimant
|
AU2009334452B2
(en)
|
2008-12-29 |
2015-06-11 |
Tel Hashomer Medical Research, Infrastructure And Services Ltd |
Peptides and compositions for prevention of cell adhesion and methods of using same
|
US8455263B2
(en)
|
2008-12-30 |
2013-06-04 |
Jin Po Lee |
Quantitative analyte assay device and method
|
WO2010076794A1
(fr)
|
2008-12-31 |
2010-07-08 |
Technion Research & Development Foundation Ltd. |
Procédé pour dénitrifier une saumure et systèmes aptes à une telle dénitrification
|
WO2010080769A2
(fr)
|
2009-01-06 |
2010-07-15 |
Arresto Biosciences, Inc. |
Procédés et compositions chimiothérapeutiques
|
IL196820A0
(en)
|
2009-02-01 |
2009-11-18 |
Yissum Res Dev Co |
Devitalized, acellular scaffold matrices derived from micro-organs seeded with various cells
|
WO2010086867A2
(fr)
|
2009-02-02 |
2010-08-05 |
Ramot At Tel Aviv University Ltd. |
Peptides, compositions pharmaceutiques en contenant et leurs utilisations
|
WO2010089707A1
(fr)
|
2009-02-04 |
2010-08-12 |
Yeda Research And Development Co. Ltd. |
Procédé et trousses pour déterminer la sensibilité ou la résistance d'un cancer prostatique à une radiothérapie
|
EP2401362B1
(fr)
|
2009-02-26 |
2017-04-12 |
Tel HaShomer Medical Research Infrastructure and Services Ltd. |
Populations isolées de cellules souches rénales et leurs procédés d'isolement et d'utilisation
|
AR075773A1
(es)
|
2009-03-02 |
2011-04-27 |
Evogene Ltd |
Polipetidos y polinucleotidos aislados y metodos para su uso en el aumento del rendimiento de plantas y las caracteristicas agricolas
|
WO2010103515A2
(fr)
|
2009-03-09 |
2010-09-16 |
Ramot At Tel Aviv University Ltd. |
Compositions et procédés pour la prévention et le traitement de maladies neurodégénératives
|
WO2010103517A1
(fr)
|
2009-03-12 |
2010-09-16 |
Rappaport Family Institute For Research In The Medical Sciences |
Compositions solubles pour le traitement de maladies associées aux ligands cxcr3
|
EP2414542B1
(fr)
|
2009-03-30 |
2017-08-30 |
Tel HaShomer Medical Research Infrastructure and Services Ltd. |
Méthodes pour prévoir l'évolution clinique de la sclérose en plaque et la traiter
|
EP2344179A1
(fr)
|
2009-04-01 |
2011-07-20 |
The Medical Research, Infrastructure, And Health Services Fund Of The Tel Aviv Medical Center |
Procédé de régulation de la prolifération et de la différenciation des kératinocytes
|
EP3281947B1
(fr)
|
2009-04-03 |
2020-02-12 |
The University of Chicago |
Compositions et procédés liés aux variantes de la protéine a (spa)
|
WO2010116375A1
(fr)
|
2009-04-08 |
2010-10-14 |
Yeda Research And Development Co. Ltd. |
Peptides isolés pour réguler l'apoptose
|
LT2990421T
(lt)
|
2009-04-30 |
2018-04-25 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Anti-ceacam1 antikūnai ir jų panaudojimo būdai
|
US9182403B2
(en)
|
2009-05-19 |
2015-11-10 |
Zetiq Technologies Ltd. |
Kits for and methods of differential staining of cervical cancer cells and/or tissues
|
EP2433132B1
(fr)
|
2009-05-21 |
2018-02-21 |
The U.S.A. as represented by the Secretary, Department of Health and Human Services |
Compositions et méthodes pour la détection de l'infection hiv-1/hiv-2
|
US20120078163A1
(en)
|
2009-05-27 |
2012-03-29 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Method of generating connective tissue
|
WO2010137013A1
(fr)
|
2009-05-27 |
2010-12-02 |
Ramot At Tel Aviv University Ltd. |
Unités cristallisées de photosystème i dérivées du pois et leur utilisation dans des dispositifs solides
|
EP2435072A2
(fr)
|
2009-05-27 |
2012-04-04 |
Yeda Research and Development Co. Ltd. |
Inhibiteurs des protéasomes et leurs utilisations
|
US20120070449A1
(en)
|
2009-05-28 |
2012-03-22 |
Yeda Research And Development Co. Ltd. |
Methods of treating inflammation
|
EP3238534B1
(fr)
|
2009-06-10 |
2019-11-13 |
Evogene Ltd. |
Polynucléotides et polypeptides isolés et leurs procédés d'utilisation pour augmenter l'efficacité d'utilisation, le rendement, la vitesse de croissance, la vigueur, la biomasse, la teneur en huile et/ou la tolérance au stress abiotique de l'azote
|
CA2765779A1
(fr)
|
2009-06-24 |
2010-12-29 |
Fund For Medical Research Development Of Infrastructure And Health Servi Ces - At Rambam Medical Center |
Methodes et kits d'isolement de microparticules placentaires et utilisation dans le diagnostic des affections placentaires
|
US9663778B2
(en)
|
2009-07-09 |
2017-05-30 |
OPKO Biologies Ltd. |
Long-acting coagulation factors and methods of producing same
|
WO2011004379A1
(fr)
|
2009-07-10 |
2011-01-13 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Compositions et méthodes de traitement du cancer
|
WO2011010309A1
(fr)
|
2009-07-21 |
2011-01-27 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Méthode de diagnostic du cancer
|
GB0913442D0
(en)
|
2009-07-31 |
2009-09-16 |
Univ Ramot |
Cell-targeting nanoparticles comprising polynucleotide agents and uses thereof
|
EP2467470A2
(fr)
|
2009-08-17 |
2012-06-27 |
Technion Research & Development Foundation Ltd. |
Cellules progénitrices de péricyte et leurs procédés de génération et d'utilisation
|
BR112012008054A2
(pt)
|
2009-08-21 |
2017-05-23 |
Gilead Biologics Inc |
domínios catalíticos de lisil oxidase e loxl2
|
EP2467146A1
(fr)
|
2009-08-21 |
2012-06-27 |
Beeologics Inc. |
Prévention et traitement de maladies des insectes bénéfiques par l intermédiaire de molécules transcrites végétales
|
KR20120054077A
(ko)
*
|
2009-08-21 |
2012-05-29 |
길리아드 바이오로직스, 인크. |
폐 섬유증 장애의 치료를 위한 방법 및 조성물
|
WO2011022670A1
(fr)
*
|
2009-08-21 |
2011-02-24 |
Arresto Biosciences, Inc |
Essais de criblage in vivo
|
US20110207144A1
(en)
*
|
2009-08-21 |
2011-08-25 |
Derek Marshall |
In vitro screening assays
|
WO2011022710A1
(fr)
*
|
2009-08-21 |
2011-02-24 |
Arresto Biosciences, Inc |
Procédés thérapeutiques et compositions afférentes
|
WO2011024172A2
(fr)
|
2009-08-27 |
2011-03-03 |
Technion Research & Development Foundation Ltd. |
Compositions liposomales et leurs utilisations
|
EP2475784A1
(fr)
|
2009-09-08 |
2012-07-18 |
Ramot at Tel-Aviv University Ltd. |
Procédés de diagnostic de la sclérose latérale amyotrophique (sla)
|
US9610331B2
(en)
|
2009-09-08 |
2017-04-04 |
Yeda Research And Development Co. Ltd. |
Methods for hematopoietic precursor mobilization
|
WO2011030329A1
(fr)
|
2009-09-10 |
2011-03-17 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Méthode de traitement de tumeurs
|
WO2011033506A2
(fr)
|
2009-09-17 |
2011-03-24 |
Yeda Research And Development Co. Ltd. |
Polypeptides pon1 isolés, polynucléotides codant pour ceux-ci et utilisations de ceux-ci dans le traitement ou la prévention des dommages associés à l'exposition à un organophosphate
|
CA2773935C
(fr)
|
2009-09-17 |
2018-06-19 |
Ramot At Tel Aviv University Ltd. |
Peptides pour le traitement de troubles lies au stress oxydatif
|
US8735124B2
(en)
|
2009-09-17 |
2014-05-27 |
Yeda Research And Development Co. Ltd. |
Isolated PON1 polypeptides, polynucleotides encoding same and uses thereof in treating or preventing organophosphate exposure associated damage
|
US20110081706A1
(en)
*
|
2009-10-02 |
2011-04-07 |
TransAlgae Ltd |
Method and system for efficient harvesting of microalgae and cyanobacteria
|
US8962584B2
(en)
|
2009-10-14 |
2015-02-24 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd. |
Compositions for controlling Varroa mites in bees
|
EP3272869B1
(fr)
|
2009-10-14 |
2020-06-24 |
Yissum Research Development Company of The Hebrew University of Jerusalem Ltd. |
Compositions pour commander les mites varroas dans les abeilles
|
ES2609006T3
(es)
|
2009-10-16 |
2017-04-18 |
Rutgers, The State University Of New Jersey |
Procedimeinto de tratamiento de lesión crónica de tejido nervioso usando una estrategia de terapia celular
|
WO2011048600A1
(fr)
|
2009-10-21 |
2011-04-28 |
Danziger Innovations Ltd. |
Génération de variations génotypiques dans des génomes de plantes par infection d'un gamète
|
IL201999A
(en)
|
2009-11-08 |
2017-10-31 |
Medical Res & Development Fund For Health Services Bnai Zion Medical Center The State Of Israel |
A knockout mouse of the 1 – mo gene, a gene associated with morbidly extreme obesity
|
WO2011058555A1
(fr)
|
2009-11-12 |
2011-05-19 |
Yeda Research And Development Co. Ltd. |
Procédé d'édition de l'adn dans une cellule et constructions ayant cette capacité
|
EP2498806B1
(fr)
|
2009-11-12 |
2014-12-31 |
Ramot at Tel-Aviv University Ltd. |
Compositions contenant du pedf et leurs utilisations dans le traitement et la prévention de syndromes liés aux ovaires
|
EP4166652A1
(fr)
|
2009-11-12 |
2023-04-19 |
Technion Research & Development Foundation Ltd. |
Milieux de culture, cultures cellulaires et procédés de culture de cellules souches pluripotentes dans un état indifférencié
|
WO2011061736A1
(fr)
|
2009-11-17 |
2011-05-26 |
Protalix Ltd. |
Alpha galactosidase alcaline pour le traitement de la maladie de fabry
|
US20130183326A9
(en)
|
2009-11-20 |
2013-07-18 |
St. Jude Children's Research Hospital |
Methods and compositions for modulating the activity of the interleukin-35 receptor complex
|
US20120273993A1
(en)
|
2009-11-24 |
2012-11-01 |
Collplant Ltd. |
Method of generating collagen fibers
|
WO2011064669A2
(fr)
|
2009-11-30 |
2011-06-03 |
Pluristem Ltd. |
Cellules adhérentes du placenta et leur utilisation dans le traitement de pathologies
|
WO2011067745A2
(fr)
|
2009-12-06 |
2011-06-09 |
Rosetta Green Ltd. |
Compositions et procédés d'amélioration de résistance de plantes au stress abiotique
|
US8778904B2
(en)
|
2009-12-09 |
2014-07-15 |
Quark Pharmaceuticals, Inc. |
Methods and compositions for treating diseases, disorders or injury of the CNS
|
US9493785B2
(en)
|
2009-12-28 |
2016-11-15 |
Evogene Ltd. |
Isolated polynucleotides and polypeptides and methods of using same for increasing plant yield, biomass, growth rate, vigor, oil content, abiotic stress tolerance of plants and nitrogen use efficiency
|
AU2010337829B2
(en)
|
2009-12-29 |
2015-03-19 |
Gamida-Cell Ltd. |
Methods for enhancing natural killer cell proliferation and activity
|
CA2786374C
(fr)
|
2010-01-05 |
2019-01-22 |
Vascular Biogenics Ltd. |
Procedes pour l'utilisation d'un agent adenoviral antiangiogenese specifique
|
SG182490A1
(en)
|
2010-01-12 |
2012-08-30 |
Vascular Biogenics Ltd |
Methods of producing adenovirus vectors and viral preparations generated thereby
|
EA201270701A1
(ru)
|
2010-01-27 |
2013-01-30 |
Йеда Рисеч Энд Девелопмент Ко. Лтд. |
Ингибирующие металлопротеины антитела
|
RU2549684C2
(ru)
|
2010-02-04 |
2015-04-27 |
Джилид Байолоджикс, Инк. |
Антитела, связывающиеся с лизилоксидазоподобным ферментом-2 (loxl2), и способы их применения
|
US9410131B2
(en)
|
2010-02-11 |
2016-08-09 |
Yeda Research And Development Co. Ltd. |
Enzymatic systems for carbon fixation and methods of generating same
|
US10080799B2
(en)
|
2010-02-12 |
2018-09-25 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Methods and compositions related to glycoprotein-immunoglobulin fusions
|
WO2011104708A2
(fr)
|
2010-02-24 |
2011-09-01 |
Ben Gurion University Of The Negev Research And Development Authority |
Méthodes d'inhibition de la nécrose
|
WO2011107939A1
(fr)
|
2010-03-01 |
2011-09-09 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Méthodes de prédiction de l'efficacité d'un traitement par anti-vegfa pour des tumeurs solides
|
WO2011107994A1
(fr)
|
2010-03-04 |
2011-09-09 |
Yeda Research And Development Co. Ltd. |
Procédés de mesure de la stabilité d'une protéine
|
WO2011111034A1
(fr)
|
2010-03-08 |
2011-09-15 |
Yeda Research And Development Co. Ltd. |
Production de protéines recombinantes dans des systèmes hétérologues
|
ES2809679T3
(es)
|
2010-03-08 |
2021-03-05 |
Monsanto Technology Llc |
Moléculas polinucleotídicas para la regulación génica en plantas
|
US20120329089A1
(en)
|
2010-03-11 |
2012-12-27 |
Jacob Edrei |
Methods of generating hydrogen
|
EP2556085A2
(fr)
|
2010-04-05 |
2013-02-13 |
Bar-Ilan University |
Polypeptides formant des pores pouvant être activés par une protéase
|
US8808699B2
(en)
|
2010-04-05 |
2014-08-19 |
The University Of Chicago |
Compositions and methods related to protein A (SpA) antibodies as an enhancer of immune response
|
WO2011128895A2
(fr)
|
2010-04-12 |
2011-10-20 |
Ben Gurion University Of The Negev Research And Development Authority |
Sulfotransférase d'une microalgue rouge et utilisations de celle-ci
|
US8927274B2
(en)
|
2010-04-12 |
2015-01-06 |
Technion Research & Development Foundation Limited |
Populations of pancreatic progenitor cells and methods of isolating and using same
|
JP5858984B2
(ja)
|
2010-04-18 |
2016-02-10 |
イェダ リサーチ アンド デベロップメント カンパニー リミテッド |
ErbB/ErbBリガンドに関連する疾患を治療するための分子及びその分子を使用する方法
|
BR122021002337B1
(pt)
|
2010-04-28 |
2022-03-22 |
Evogene Ltd |
Método de aumento de produção, biomassa, taxa de crescimento, vigor, teor de óleo, produção de fibra qualidade de fibra, tolerância ao estresse abiótico e/ou eficiência de uso de nitrogênio de uma planta, e construto de ácido nucleico isolado
|
US20130053277A1
(en)
|
2010-05-04 |
2013-02-28 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Methods of identifying inhibitors of polypeptides-of-interest
|
WO2011138785A2
(fr)
|
2010-05-05 |
2011-11-10 |
Rappaport Family Institute For Research In The Medical Sciences |
Utilisation thérapeutique de ccl1
|
IL208820A0
(en)
|
2010-10-19 |
2011-01-31 |
Rachel Teitelbaum |
Biologic female contraceptives
|
WO2011141914A1
(fr)
|
2010-05-13 |
2011-11-17 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Populations isolées de cellules rénales adultes et procédés d'isolement et d'utilisation desdites populations
|
US9624285B2
(en)
|
2010-06-03 |
2017-04-18 |
Ramot a Tel-Aviv University Ltd. |
Methods of treating diabetes and compositions capable of same
|
AU2011263306A1
(en)
|
2010-06-07 |
2013-01-10 |
Osnat Ashur-Fabian |
Methods and kits for diagnosing conditions related to hypoxia
|
BR112012032126A2
(pt)
|
2010-06-16 |
2017-10-17 |
Futuragene Israel Ltd Empresa Isralense |
polinucleotídeo isolado, estrutura de ácido nucléico, sistema de estrutura de ácido nucléico, polipeptídeo isolado, planta, composição inseticida, e método para controlar ou exterminar um inseto
|
WO2011158243A2
(fr)
|
2010-06-16 |
2011-12-22 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Procédé de diagnostic et de traitement du cancer
|
SG186290A1
(en)
|
2010-07-02 |
2013-01-30 |
Univ Chicago |
Compositions and methods related to protein a (spa) variants
|
ES2817780T3
(es)
|
2010-07-12 |
2021-04-08 |
The State Of Israel Ministry Of Agriculture And Rural Development Agricultural Res Organization A R |
Polinucleótidos aislados y métodos y plantas que usan los mismos para regular la acidez de las plantas
|
EP2593554A2
(fr)
|
2010-07-15 |
2013-05-22 |
Technion Research And Development Foundation Ltd. |
Construction d'acide nucléique destinée à accroître la tolérance au stress abiotique dans des végétaux
|
EP2593480A2
(fr)
|
2010-07-15 |
2013-05-22 |
Technion Research & Development Foundation Ltd. |
Entités de haute affinité isolées présentant une spécificité de type récepteur des lymphocytes t pour les complexes natifs du mhc de classe ii et les peptides auto-antigéniques associés au diabète
|
BR112013000985A2
(pt)
|
2010-07-15 |
2017-09-05 |
Technion Res & Dev Foundation |
Entidades isoladas de alta afinidade com especificidade semelhante à do receptor de célula t em relação a complexos nativos de mhc classe ii e peptídeos autoantigênicos de descarboxilase do ácido glutâmico (gad)
|
US9624469B2
(en)
|
2010-07-22 |
2017-04-18 |
Cellect Biotherapeutics Ltd. |
Regulatory immune cells with enhanced targeted cell death effect
|
US9144585B2
(en)
|
2010-07-27 |
2015-09-29 |
Technion Research & Development Foundation Limited |
Isolated mesenchymal progenitor cells and extracellular matrix produced thereby
|
US20130130387A1
(en)
|
2010-07-27 |
2013-05-23 |
Technion Research & Development Foundation Limited |
Method for generating induced pluripotent stem cells from keratinocytes derived from plucked hair follicles
|
US20130130311A1
(en)
|
2010-07-27 |
2013-05-23 |
Yeda Research And Development Co., Ltd. |
Methods and systems for assessing clonality of cell cultures
|
US8901074B2
(en)
|
2010-08-04 |
2014-12-02 |
Ramot At Tel-Aviv University |
Methods of treating autoimmune diseases of the central nervous system (CNS) and neurodegenerative diseases
|
US9394523B2
(en)
|
2010-08-22 |
2016-07-19 |
Ramot At Tel-Aviv University Ltd. |
Induced pluripotent stem cells derived from human pancreatic beta cells
|
WO2012025925A1
(fr)
|
2010-08-24 |
2012-03-01 |
Rappaport Family Institute For Research In The Medical Sciences |
Procédés d'amélioration de la transplantation en utilisant des sdf-1alpha
|
BR122019017037B1
(pt)
|
2010-08-30 |
2022-05-31 |
Evogene Ltd |
Método de aumento de eficiência do uso de nitrogênio, rendimento, biomassa, taxa de crescimento, vigor e/ou tolerância ao estresse à deficiência de nitrogênio de uma planta
|
EP2613799A1
(fr)
|
2010-09-07 |
2013-07-17 |
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. |
Translecture d'acétylcholinestérase (ache-r) pour le traitement ou la prévention de la maladie de parkinson
|
SG188411A1
(en)
|
2010-09-07 |
2013-04-30 |
Technion Res & Dev Foundation |
Novel methods and culture media for culturing pluripotent stem cells
|
WO2012032510A1
(fr)
|
2010-09-07 |
2012-03-15 |
Yeda Research And Development Co. Ltd. |
Amorces pour l'amplification d'adn et procédés de sélection de ces dernières
|
WO2012032519A2
(fr)
|
2010-09-07 |
2012-03-15 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Méthodes de diagnostic de la maladie de parkinson
|
PT2613801T
(pt)
|
2010-09-08 |
2016-09-12 |
Yeda Res & Dev |
Utilização de células t de memória central anti-terceiros no tratamento anti-leucemia/linfoma
|
MX2013002667A
(es)
|
2010-09-08 |
2013-08-01 |
Yeda Res & Dev |
Una combinacion de farmacos inmunosupresores para un injerto estable y a largo plazo.
|
EP2614074A1
(fr)
|
2010-09-09 |
2013-07-17 |
The University of Chicago |
Procédés et compositions impliquant des antigènes staphylococciques protecteurs
|
WO2012035539A1
(fr)
|
2010-09-15 |
2012-03-22 |
Ramot At Tel-Aviv University Ltd. |
Procédés d'expansion et de redifférenciation de cellules bêta des îlots
|
US20130210901A1
(en)
|
2010-09-20 |
2013-08-15 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Method of treating neurodegenerative diseases
|
EP2627766B1
(fr)
|
2010-10-17 |
2016-05-25 |
Yeda Research and Development Co. Ltd. |
Procédés et compositions utilisables en vue du traitement de pathologies médicales associées à l'insuline
|
WO2012052878A1
(fr)
|
2010-10-19 |
2012-04-26 |
Vascular Biogenics Ltd. |
Polynucléotides isolés et constructions d'acide nucléique pour diriger l'expression d'un gène d'intérêt dans des cellules
|
WO2012056452A2
(fr)
|
2010-10-27 |
2012-05-03 |
Nanocyte (Israel) Ltd. |
Compositions pharmaceutiques et dispositifs d'administration comprenant des cellules ou capsules urticantes
|
WO2012056455A1
(fr)
|
2010-10-28 |
2012-05-03 |
Yeda Research And Development Co. Ltd. |
Procédés de génération d'anticorps anti-métalloenzymes
|
US20130227724A1
(en)
|
2010-11-03 |
2013-08-29 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Transgenic plants with improved saccharification yields and methods of generating same
|
US9410132B2
(en)
|
2010-11-04 |
2016-08-09 |
Ben-Gurion University Of The Negev Research And Development Authority |
Acyl-CoA: diacylglycerol acyltransferase 1-like gene (PtDGAT1) and uses thereof
|
WO2012066549A1
(fr)
|
2010-11-15 |
2012-05-24 |
Ramot At Tel-Aviv University Ltd. |
Analogues dipeptidiques pour le traitement d'états pathologiques associé à la formation de fibrilles amyloïdes
|
EP2640404B1
(fr)
|
2010-11-17 |
2017-02-22 |
Ben Gurion University of The Negev Research and Development Authority |
Thérapie à base de cellules t pour les maladies neurodégénératives
|
WO2012075111A1
(fr)
|
2010-11-30 |
2012-06-07 |
Novartis Ag |
Utilisation d'anticorps anti-cd40 en thérapie combinée contre des cancers associés aux cellules b
|
WO2012073238A1
(fr)
|
2010-12-02 |
2012-06-07 |
Technion Research & Development Foundation Ltd. |
Procédé de génération de cellules cornéennes et populations de cellules les comprenant
|
EP2463382A1
(fr)
|
2010-12-07 |
2012-06-13 |
Enterologics, Inc. |
Procédé d'identification de E. Coli M-17
|
EP2652125B1
(fr)
|
2010-12-15 |
2017-04-26 |
Kadimastem Ltd. |
Cellules produisant de l'insuline dérivées de cellules souches pluripotentes
|
US9551006B2
(en)
|
2010-12-22 |
2017-01-24 |
Evogene Ltd. |
Isolated polynucleotides and polypeptides, and methods of using same for improving plant properties
|
EP2658562B1
(fr)
|
2010-12-28 |
2017-07-26 |
Kamedis Ltd. |
Extraits de plantes pour le traitement et prévention d'infections
|
PT3272861T
(pt)
|
2011-01-20 |
2020-03-26 |
Protalix Ltd |
Construção de ácido nucleico para expressão de alfα-galactosidase em plantas e células de plantas
|
US20130316358A1
(en)
|
2011-01-31 |
2013-11-28 |
Yeda Research And Development Co. Ltd. |
Methods of diagnosing disease using overlap extension pcr
|
US20130330349A1
(en)
|
2011-02-23 |
2013-12-12 |
Rappaport Family Institute For Research In The Medical Sciences |
High affinity molecules capable of binding a type a plexin receptor and uses of same
|
EP2492279A1
(fr)
|
2011-02-25 |
2012-08-29 |
Laboratorios Del. Dr. Esteve, S.A. |
Procédé de sélection rapide d'immunogène par expression à la surface du lentivirus.
|
WO2012117406A2
(fr)
|
2011-03-02 |
2012-09-07 |
Futuragene Israel Ltd. |
Plantes transgéniques résistantes aux bactéries
|
EP2680864B1
(fr)
|
2011-03-03 |
2019-05-08 |
Ramot at Tel-Aviv University Ltd. |
Cellules musculaires génétiquement modifiées qui expriment des facteurs neurotrophiques
|
CA2829110C
(fr)
|
2011-03-06 |
2019-01-15 |
Merck Serono S.A. |
Lignees cellulaires a basse teneur de fucose et leurs utilisations
|
US9061006B2
(en)
|
2011-03-08 |
2015-06-23 |
Ramot At Tel-Aviv University Ltd. |
Compositions and methods for diagnosing and treating phenylketonuria (PKU)
|
BR112013023653A2
(pt)
|
2011-03-17 |
2016-12-13 |
Univ Ramot |
anticorpo biespecífico, método de preparação do anticorpo, e composição farmacêutica
|
CN103533934B
(zh)
|
2011-03-17 |
2016-03-30 |
特尔汗什莫尔医学基础设施研究和服务公司 |
用于治疗自身免疫性疾病的喹诺酮类似物
|
KR101903339B1
(ko)
|
2011-03-22 |
2018-10-01 |
플루리스템 리미티드 |
방사선 또는 화학적 손상을 치료하는 방법
|
JP5960793B2
(ja)
|
2011-03-24 |
2016-08-02 |
ニューリム ファーマシューティカルズ(1991)リミテッド |
神経保護ペプチド
|
WO2012131680A2
(fr)
|
2011-03-28 |
2012-10-04 |
Yeda Research And Development Co. Ltd. |
Compositions et procédés pour le traitement de l'inflammation
|
WO2012137202A1
(fr)
|
2011-04-05 |
2012-10-11 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Composition comprenant un indicateur de fer attaché à une microparticule et utilisations de celle-ci pour quantifier du fer non lié à la transferrine (ntbi) et du fer labile cellulaire (lci)
|
KR102010600B1
(ko)
|
2011-04-06 |
2019-08-13 |
라모트 앳 텔-아비브 유니버시티 리미티드 |
대사 활성 프로필을 모니터링 및 분석하는 방법 및 그의 진단 및 치료학적 용도
|
WO2012142164A1
(fr)
|
2011-04-12 |
2012-10-18 |
The United States Of America, As Represented By The Secretary, Department Of Health & Human Services |
Anticorps monoclonaux humains qui se lient aux facteurs de croissance insulinomimétique (igf) de type i et ii
|
CA2832812C
(fr)
|
2011-04-15 |
2017-12-05 |
Pluristem Ltd. |
Procedes et systemes de recolte de cellules
|
CA3137817A1
(fr)
|
2011-05-03 |
2012-11-08 |
Evogene Ltd. |
Polynucleotides et polypeptides isoles et leurs procedes d'utilisation pour augmenter le rendement de plantes, la biomasse, la vitesse de croissance, la vigueur, la teneur en huile, la tolerance au stress abiotique de plantes et l'efficacite d'utilisation de l'azote
|
EP2704793B1
(fr)
|
2011-05-04 |
2019-07-17 |
Ramot at Tel Aviv University, Ltd. |
Régulation de la composition moléculaire des bêta amyloïdes pour le traitement de la maladie d'azheimer
|
US8945588B2
(en)
|
2011-05-06 |
2015-02-03 |
The University Of Chicago |
Methods and compositions involving protective staphylococcal antigens, such as EBH polypeptides
|
WO2012153333A1
(fr)
|
2011-05-09 |
2012-11-15 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Régénération et réparation de tissu mésenchymateux par utilisation d'amélogénine
|
WO2012153336A2
(fr)
|
2011-05-12 |
2012-11-15 |
Rakuto Bio Technologies Ltd. |
Procédés et dispositifs pour éclaircir la carnation de la peau
|
WO2012156976A1
(fr)
|
2011-05-16 |
2012-11-22 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Procédés de préparation d'artémisinine dans des plantes non-hôtes et vecteurs destinés à une utilisation dans celles-ci
|
WO2012160526A2
(fr)
|
2011-05-23 |
2012-11-29 |
Ofir Menashe |
Formulations à base de particules contenant des micro-organismes et leurs utilisations
|
WO2012160563A2
(fr)
|
2011-05-23 |
2012-11-29 |
Yeda Research And Development Co. Ltd. |
Utilisation de la phosphorylation d'akt en tant que biomarqueur pour le pronostic et le traitement de maladies neurodégénératives
|
EP2714719B1
(fr)
|
2011-05-31 |
2018-12-12 |
Hutchison Biofilm Medical Solutions Limited |
Dispersion et détachement d'agrégats cellulaires
|
US20140113376A1
(en)
|
2011-06-01 |
2014-04-24 |
Rotem Sorek |
Compositions and methods for downregulating prokaryotic genes
|
US10166295B2
(en)
|
2011-06-02 |
2019-01-01 |
Opko Biologics Ltd. |
Pegylated OXM variants
|
EP2720720B1
(fr)
|
2011-06-14 |
2018-02-28 |
Yeda Research and Development Co. Ltd. |
Plurithérapie destinée à empêcher la formation de dcis et l'évolution en un cancer du sein
|
WO2012176203A1
(fr)
|
2011-06-23 |
2012-12-27 |
Kaiima Bio Agritech Ltd. |
Blé commun, plantes ou parties de celles-ci ayant un génome partiellement ou complètement multiplié, hybrides et produits de ceux-ci, et procédés de génération et d'utilisation
|
MX352338B
(es)
|
2011-07-18 |
2017-11-17 |
Inst Res Biomedicine |
Anticuerpos neutralizantes del virus de la influenza a y usos de estos.
|
RU2014106125A
(ru)
|
2011-07-20 |
2015-08-27 |
Каиима Био Агритех Лтд. |
Растения кукурузы с частично или полностью умноженным геномом и их применения
|
EP2550982A1
(fr)
|
2011-07-27 |
2013-01-30 |
Technion Research & Development Foundation Ltd. |
Dispositifs pour applications chirurgicales
|
CA2844012C
(fr)
|
2011-08-04 |
2021-03-16 |
Yeda Research And Development Co. Ltd. |
Micro-arn et compositions les comprenant pour le traitement et le diagnostic de troubles medicaux associes a la serotonine, a l'adrenaline, a la noradrenaline, au glutamate et a l'hormone de liberation de la corticotropine
|
WO2013021389A2
(fr)
|
2011-08-09 |
2013-02-14 |
Yeda Research And Development Co.Ltd. |
Régulation à la baisse de mir-7 pour favoriser la différenciation des cellules bêta et la production d'insuline
|
AU2012296138A1
(en)
|
2011-08-14 |
2014-03-06 |
Kaiima Bio Agritech Ltd. |
Durum wheat plants having a partially or fully multiplied genome and uses thereof
|
WO2013035070A1
(fr)
|
2011-09-07 |
2013-03-14 |
Yeda Research And Development Co. Ltd. |
Signature olfactive et mélange odorant la contenant
|
AU2012305931B2
(en)
|
2011-09-08 |
2017-09-07 |
Yeda Research And Development Co. Ltd |
Anti third party central memory T cells, methods of producing same and use of same in transplantation and disease treatment
|
CN103890195A
(zh)
|
2011-09-08 |
2014-06-25 |
耶达研究及发展有限公司 |
用于肺癌的新型风险生物标志物
|
EP2755466A4
(fr)
|
2011-09-13 |
2015-04-15 |
Monsanto Technology Llc |
Procédés et compositions de lutte contre les mauvaises herbes
|
CA2848680C
(fr)
|
2011-09-13 |
2020-05-19 |
Monsanto Technology Llc |
Procedes et compositions de lutte contre les mauvaises herbes
|
US10760086B2
(en)
|
2011-09-13 |
2020-09-01 |
Monsanto Technology Llc |
Methods and compositions for weed control
|
US10806146B2
(en)
|
2011-09-13 |
2020-10-20 |
Monsanto Technology Llc |
Methods and compositions for weed control
|
US10829828B2
(en)
|
2011-09-13 |
2020-11-10 |
Monsanto Technology Llc |
Methods and compositions for weed control
|
EP3296402B1
(fr)
|
2011-09-13 |
2020-04-15 |
Monsanto Technology LLC |
Procédés et compositions pour lutter contre les mauvaises herbes
|
BR112014005979A8
(pt)
|
2011-09-13 |
2017-09-12 |
Monsanto Technology Llc |
Métodos e composições quimicas agricolas para controle de planta, método de redução de expressão de um gene ppg oxidase em uma planta, cassete de expressão microbiana, método para fazer um polinucleotídeo, método de identificação de polinucleotídeos úteis na modulação de expressão do gene ppg oxidase e mistura herbicida
|
WO2013054320A1
(fr)
|
2011-10-11 |
2013-04-18 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Anticorps dirigés contre la molécule d'adhésion cellulaire associée à l'antigène carcino-embryonnaire (ceacam)
|
BR112014009536A2
(pt)
|
2011-10-21 |
2017-04-18 |
Augurex Life Sciences Corp |
antígenos derivados de 14-3-3 xitrulinada e usos dos mesmos no diagnóstico de artrite reumatoide
|
WO2013061328A2
(fr)
|
2011-10-27 |
2013-05-02 |
Yeda Research And Development Co. Ltd. |
Procédé de traitement du cancer
|
EP2773758B1
(fr)
|
2011-11-03 |
2017-06-07 |
Quark Pharmaceuticals, Inc. |
Compositions pour la neuroprotection
|
EP2776565A1
(fr)
|
2011-11-08 |
2014-09-17 |
Quark Pharmaceuticals, Inc. |
Méthodes et compositions destinées à traiter des maladies, des troubles ou une lésion du système nerveux
|
US9736998B2
(en)
|
2011-11-23 |
2017-08-22 |
Danziger Dan Flower Farm |
Otomeria plants
|
WO2013076730A1
(fr)
|
2011-11-27 |
2013-05-30 |
Yeda Research And Development Co. Ltd. |
Méthodes de régulation de l'angiogenèse et compositions capables de réguler l'angiogenèse
|
SG11201402902VA
(en)
|
2011-12-08 |
2014-07-30 |
Yeda Res & Dev |
Mammalian fetal pulmonary cells and therapeutic use of same
|
WO2013093921A1
(fr)
|
2011-12-20 |
2013-06-27 |
Collplant Ltd. |
Fibres de polymère synthétique enrobées de collagène
|
RU2648354C2
(ru)
|
2011-12-22 |
2018-03-23 |
Иеда Рисеч Энд Девелопмент Ко. Лтд. |
Комбинированная терапия для стабильного и долговременного приживления трансплантата с использованием конкретных протоколов для т/в-клеточной деплеции
|
CN105833925B
(zh)
|
2011-12-22 |
2018-11-13 |
瑞尔比奥技术有限公司 |
用于分析物测定的序贯侧向流动毛细管装置
|
CN104270939A
(zh)
|
2011-12-28 |
2015-01-07 |
凯伊玛生物农业科技有限公司 |
具有部分加倍或完全加倍的基因组的栽培高粱植物及其应用
|
CN104080480A
(zh)
|
2012-01-01 |
2014-10-01 |
奇比艾企业有限公司 |
用于选择性递送治疗剂和诊断剂的endo180靶向微粒
|
WO2013114363A2
(fr)
|
2012-01-30 |
2013-08-08 |
Yeda Research And Development Co.Ltd. |
Agents antimicrobiens
|
US20150010527A1
(en)
|
2012-02-01 |
2015-01-08 |
Protalix Ltd. |
Dnase i polypeptides, polynucleotides encoding same, methods of producing dnase i and uses thereof in therapy
|
WO2013118120A2
(fr)
|
2012-02-06 |
2013-08-15 |
Rosetta Green Ltd. |
Polynucléotides isolés exprimant ou modulant des microarn ou des cibles de ceux-ci, plantes transgéniques comprenant ceux-ci et leurs utilisations dans l'amélioration de l'efficacité d'utilisation de l'azote, de la tolérance au stress abiotique, de la biomasse, de la vigueur ou du rendement d'une plante
|
BR112014020119A2
(pt)
|
2012-02-13 |
2020-10-27 |
Gamida-Cell Ltd |
cultura de células-tronco mesenquimais
|
EP2822576B1
(fr)
|
2012-02-14 |
2018-01-10 |
OPKO Biologics Ltd. |
Facteurs de coagulation à action prolongée et leurs procédés de production
|
KR20140130495A
(ko)
|
2012-02-19 |
2014-11-10 |
프로탈릭스 리미티드 |
고셰병 치료용 경구형 단위 투약 형태 및 이의 용도
|
EP2844745A2
(fr)
|
2012-02-22 |
2015-03-11 |
Brainstem Biotec Ltd. |
Génération de cellules souches neuronales et de motoneurones
|
EP3401393B1
(fr)
|
2012-02-22 |
2020-02-19 |
Exostem Biotec Ltd |
Microarn pour la génération d'astrocytes
|
EP2833714A1
(fr)
|
2012-03-01 |
2015-02-11 |
The State of Israel - Ministry of Agriculture & Rural Development, Agricultural Research Organization (ARO) (Volcani Center) |
Plantes d'ail stérile mâle, descendance hybride de celles-ci et procédés de génération et d'utilisation de celles-ci
|
ES2691931T3
(es)
|
2012-03-07 |
2018-11-29 |
Yeda Research And Development Co. Ltd. |
Composiciones para inhibición de quiescina sulfhidrilo oxidasa (QSOX1) y usos de las mismas
|
US9498531B2
(en)
|
2012-03-20 |
2016-11-22 |
Humabs Biomed Sa |
Antibodies that neutralize RSV, MPV and PVM and uses thereof
|
EP2828280B1
(fr)
|
2012-03-22 |
2018-05-02 |
Ramot at Tel-Aviv University Ltd. |
Peptides multimères plif et utilisations de ceux-ci
|
US9283272B2
(en)
|
2012-03-30 |
2016-03-15 |
The United States Of America As Represented By The Department Of Veterans Affairs |
Targeting intracellular target-binding determinants with intracellular antibodies
|
AU2013250767A1
(en)
|
2012-04-18 |
2014-10-09 |
Quiet Therapeutics Ltd. |
Lipidated glycosaminoglycan particles for the delivery of nucleic acids
|
EP2838552A4
(fr)
|
2012-04-19 |
2016-05-18 |
Opko Biolog Ltd |
Variants d'oxyntomoduline à action prolongée et procédés pour les produire
|
EP2841084B1
(fr)
|
2012-04-24 |
2018-05-30 |
Biokine Therapeutics Ltd. |
Peptide antagoniste de cxcr4 et son utilisation pour le traitment de tumeurs pulmonaires
|
US9968668B2
(en)
|
2012-04-26 |
2018-05-15 |
The University Of Chicago |
Staphylococcal coagulase antigens and methods of their use
|
JP6181158B2
(ja)
|
2012-05-09 |
2017-08-16 |
イェダ リサーチ アンド デベロップメント カンパニー リミテッド |
TNF−α阻害剤としてのTACEプロドメインの変異体およびその医学的使用
|
US8865158B2
(en)
|
2012-05-22 |
2014-10-21 |
Ramot At Tel-Aviv University Ltd. |
Bacteriophages for reducing toxicity of bacteria
|
US10240162B2
(en)
|
2012-05-24 |
2019-03-26 |
A.B. Seeds Ltd. |
Compositions and methods for silencing gene expression
|
JP5868549B2
(ja)
|
2012-05-24 |
2016-02-24 |
マウントゲイト グループ リミテッド |
狂犬病感染の予防および治療に関する組成物および方法
|
US9731048B2
(en)
|
2012-06-03 |
2017-08-15 |
Ben-Gurion University Of The Negev Research And Development Authority |
Functionalized titanium binding peptides and implants coated with same
|
PE20150181A1
(es)
|
2012-06-04 |
2015-02-28 |
Opko Biolog Ltd |
Variantes de oxm pegilada
|
EP2870110A1
(fr)
|
2012-07-03 |
2015-05-13 |
Nanospun Technologies Ltd. |
Procédés et dispositifs pour l'adsorption et la biodégradation de pétrole
|
US9567569B2
(en)
|
2012-07-23 |
2017-02-14 |
Gamida Cell Ltd. |
Methods of culturing and expanding mesenchymal stem cells
|
US9175266B2
(en)
|
2012-07-23 |
2015-11-03 |
Gamida Cell Ltd. |
Enhancement of natural killer (NK) cell proliferation and activity
|
EP2880155B1
(fr)
|
2012-07-29 |
2019-04-17 |
Yeda Research and Development Co., Ltd. |
Utilisation de la voie de la glycine réductrice en vue de la génération de microorganismes formatotrophes et autotrophes
|
JP6340366B2
(ja)
|
2012-07-31 |
2018-06-06 |
イェダ リサーチ アンド デベロップメント カンパニー リミテッド |
運動ニューロン疾患を診断および処置する方法
|
ES2813407T3
(es)
|
2012-08-06 |
2021-03-23 |
Brainstorm Cell Therapeutics Ltd |
Métodos para generar células madre mesenquimales que secretan factores neurotróficos
|
EP2698377A1
(fr)
|
2012-08-17 |
2014-02-19 |
Laboratorios Del. Dr. Esteve, S.A. |
Procédé de sélection rapide d'immunogène de variants de la GP-120 du VIH amélioré
|
WO2014033723A1
(fr)
|
2012-09-03 |
2014-03-06 |
A.B. Seeds Ltd. |
Procédé d'amélioration de la tolérance au stress abiotique des plantes et plantes ainsi produites
|
US10543278B2
(en)
|
2012-09-12 |
2020-01-28 |
Ramot At Tel-Aviv University Ltd. |
Immunoparticles and methods of generating and using same
|
EP2900685B1
(fr)
|
2012-09-27 |
2017-10-25 |
Research Development Foundation |
Virus atténué de chikungunya
|
EP2906954B1
(fr)
|
2012-10-09 |
2018-04-11 |
Ramot at Tel-Aviv University Ltd. |
Procédés et trousses utilisant la mortaline soluble dans le sang pour prédire un pronostic de cancer
|
CN104918639B
(zh)
|
2012-10-22 |
2018-01-26 |
萨拜格Rfa公司 |
用于将治疗剂递送到活细胞和细胞核中的系统
|
WO2014064682A1
(fr)
|
2012-10-24 |
2014-05-01 |
Yeda Research And Development Co. Ltd. |
Combinaisons d'anticorps ciblant les récepteurs du facteur de croissance épidermique pour traiter le cancer
|
EP2912181B1
(fr)
|
2012-10-29 |
2017-11-29 |
Yeda Research and Development Co., Ltd. |
Aptamères, aptamères multimères et leurs utilisations
|
WO2014080401A2
(fr)
|
2012-11-20 |
2014-05-30 |
Prolor Biotech Inc |
Procédé d'augmentation du volume hydrodynamique de polypeptides par la fixation à des peptides carboxy terminaux de gonadotrophine
|
WO2015079413A2
(fr)
|
2013-11-28 |
2015-06-04 |
Yeda Research And Development Co. Ltd. |
Inhibiteurs de synaptojanine-2 et leurs utilisations
|
BR112015002626A2
(pt)
|
2012-11-29 |
2017-09-26 |
Yeda Res & Dev |
métodos para prevenção de metástases tumorais, tratamento e prognostico do câncer e identificação dos agentes que são inibidores da metástase putativa
|
CN105358695B
(zh)
|
2013-01-01 |
2019-07-12 |
A.B.种子有限公司 |
将dsRNA引入植物种子以调节基因表达的方法
|
US10683505B2
(en)
|
2013-01-01 |
2020-06-16 |
Monsanto Technology Llc |
Methods of introducing dsRNA to plant seeds for modulating gene expression
|
WO2014108854A1
(fr)
|
2013-01-09 |
2014-07-17 |
Fusimab Ltd. |
Anticorps anti-hgf et anti-ang2 monospécifiques, et anticorps anti-hgf/anti-ang2 bispécifiques
|
WO2014108850A2
(fr)
|
2013-01-09 |
2014-07-17 |
Yeda Research And Development Co. Ltd. |
Analyse de transcriptome à haut débit
|
EP3431985A1
(fr)
|
2013-01-17 |
2019-01-23 |
Novellusdx Ltd. |
Procédés et systèmes pour identifier des mutations conductrices spécifiques à un patient
|
US10000737B2
(en)
|
2013-02-04 |
2018-06-19 |
Ramot At Tel-Aviv University Ltd. |
Generation of cytotoxic tumor specific cell lines and uses thereof
|
AU2014224174B2
(en)
|
2013-03-06 |
2018-08-30 |
Hadasit Medical Research Services And Development Ltd. |
Use of plant cells expressing a TNFalpha polypeptide inhibitor in therapy
|
JP6454650B2
(ja)
|
2013-03-06 |
2019-01-23 |
プロタリクス リミテッド |
TNFαポリペプチド阻害剤を発現する植物細胞及び薬学的に許容される担体を含む医薬組成物
|
WO2014138696A1
(fr)
|
2013-03-07 |
2014-09-12 |
University Of Maryland, Baltimore |
Potentiel immunothérapeutique de lipooligosaccharides/lipide a modifiés
|
US10609930B2
(en)
|
2013-03-13 |
2020-04-07 |
Monsanto Technology Llc |
Methods and compositions for weed control
|
US10612019B2
(en)
|
2013-03-13 |
2020-04-07 |
Monsanto Technology Llc |
Methods and compositions for weed control
|
US10568328B2
(en)
|
2013-03-15 |
2020-02-25 |
Monsanto Technology Llc |
Methods and compositions for weed control
|
CA2907680A1
(fr)
|
2013-03-21 |
2014-09-25 |
Collplant Ltd. |
Compositions comprenant du collagene et prp pour la regeneration tissulaire
|
CN105163749B
(zh)
|
2013-03-24 |
2018-03-27 |
拜欧肯治疗有限公司 |
治疗骨髓性白血病的方法
|
WO2014174511A1
(fr)
|
2013-04-21 |
2014-10-30 |
Yeda Research And Development Co. Ltd. |
Agents de régulation à la baisse de l'activité et/ou de la quantité de bcl-xl et/ou bcl-w
|
EP2989199B1
(fr)
|
2013-04-23 |
2020-08-12 |
Yeda Research and Development Co., Ltd. |
Cellules souches pluripotentes naïves isolées et leurs procédés de génération
|
WO2014174520A1
(fr)
|
2013-04-25 |
2014-10-30 |
Yeda Research And Development Co. Ltd. |
Utilisation de peptides inhibiteurs pour le traitement de maladies inflammatoires
|
US20160115231A1
(en)
|
2013-05-21 |
2016-04-28 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Treatment of mast cell related pathologies
|
KR102280377B1
(ko)
|
2013-05-27 |
2021-07-23 |
라쿠토 바이오 테크놀로지스 리미티드 |
효소 시스템-함유 화장료 조성물
|
ES2938044T3
(es)
|
2013-06-24 |
2023-04-04 |
Univ Ramot |
Estructura a base de epiplón y sistema de suministro
|
US9850496B2
(en)
|
2013-07-19 |
2017-12-26 |
Monsanto Technology Llc |
Compositions and methods for controlling Leptinotarsa
|
BR112016000555B1
(pt)
|
2013-07-19 |
2022-12-27 |
Monsanto Technology Llc |
Método para controlar uma infestação da espécie de leptinotarsa em uma planta, composição inseticida e construção de dna recombinante
|
WO2015015489A1
(fr)
|
2013-07-30 |
2015-02-05 |
Biolinerx Ltd. |
Anticorps convenant au traitement du diabète et de maladies autoimmunes
|
ES2702674T3
(es)
|
2013-08-29 |
2019-03-04 |
Yeda Res & Dev |
Inhibidores selectivos de la isoforma alfa2 de Na,K-ATPasa y el uso para la reducción de la presión intraocular
|
US20160251410A1
(en)
|
2013-09-03 |
2016-09-01 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Compositions and methods for expressing recombinant polypeptides
|
IL228284A
(en)
|
2013-09-03 |
2016-12-29 |
Technion Res & Dev Foundation |
Implants from cellular scaffolding and blood vessel stalk
|
WO2015033344A1
(fr)
|
2013-09-05 |
2015-03-12 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Procédés et nécessaires permettant d'inhiber la pathogénicité d'un streptocoque du groupe a (sga) ou d'un streptocoque du groupe g (sgg)
|
WO2015037009A1
(fr)
|
2013-09-16 |
2015-03-19 |
Plexicure Ltd. |
Protéines isolées capables de se lier à la plexine-a4, et procédés de production et d'utilisation
|
WO2015040609A1
(fr)
|
2013-09-17 |
2015-03-26 |
Yeda Research And Development Co. Ltd. |
Nouveaux peptides d'erk et leurs utilisations
|
AU2014330807B2
(en)
|
2013-10-01 |
2020-07-02 |
Kadimastem Ltd. |
Directed differentiation of astrocytes from human pluripotent stem cells for use in drug screening and the treatment of Amyotrophic Lateral Sclerosis (ALS)
|
CN113667013B
(zh)
|
2013-10-02 |
2024-04-09 |
免疫医疗有限责任公司 |
中和抗甲型流感抗体及其用途
|
PT3060239T
(pt)
|
2013-10-21 |
2020-08-26 |
Opko Biologics Ltd |
Polipéptidos de ação prolongada e métodos de produção e administração dos mesmos
|
US20150158926A1
(en)
|
2013-10-21 |
2015-06-11 |
Opko Biologics, Ltd. |
Long-acting polypeptides and methods of producing and administering same
|
US10767156B2
(en)
|
2013-10-24 |
2020-09-08 |
Yeda Research And Development Co., Ltd. |
Polynucleotides encoding BREX system polypeptides and methods of using same
|
US20160243187A1
(en)
|
2013-10-31 |
2016-08-25 |
Biokine Therapeutics Ltd. |
Methods of treating acute myeloid leukemia with a flt3 mutation
|
RU2694950C2
(ru)
|
2013-11-04 |
2019-07-18 |
Монсанто Текнолоджи Ллс |
Композиции и способы для борьбы с членистоногими паразитами и заражениями вредителями
|
CA2925698C
(fr)
|
2013-11-28 |
2021-11-09 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Inhibiteurs de l'arn polymerase i et leurs utilisations
|
ES2697757T3
(es)
|
2013-12-10 |
2019-01-28 |
Yeda Res & Dev |
Uso de enzimas que catalizan la síntesis de piruvato a partir de formiato y acetil-CoA y bacterias que expresan la misma
|
UA119253C2
(uk)
|
2013-12-10 |
2019-05-27 |
Біолоджикс, Інк. |
Спосіб боротьби із вірусом у кліща varroa та у бджіл
|
BR112016016337A2
(pt)
|
2014-01-15 |
2017-10-03 |
Monsanto Technology Llc |
Composição e métodos para controlar crescimento, desenvolvimento ou a capacidade de reprodução de uma planta, e para sensibilizar uma planta para um herbicida inibidor de epsps
|
WO2015114633A1
(fr)
|
2014-01-30 |
2015-08-06 |
Yissum Research And Development Company Of The Hebrew University Of Jerusalem Ltd. |
Peptides se liant à l'actine et compositions les contenant pour inhiber l'angiogenèse et traiter des affections médicales associées à celle-ci
|
CA2937992A1
(fr)
|
2014-02-03 |
2015-08-06 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Methode d'elimination de cellules souches
|
US10125365B2
(en)
|
2014-02-05 |
2018-11-13 |
Yeda Research And Development Co. Ltd. |
Micro-RNAs and compositions comprising same for the treatment and diagnosis of serotonin-, adrenalin-, noradrenalin-, glutamate-, and corticotropin-releasing hormone- associated medical conditions
|
US10066014B2
(en)
|
2014-02-06 |
2018-09-04 |
Yeda Research And Development Co. Ltd. |
Anti CD84 antibodies, compositions comprising same and uses thereof
|
US20170101633A1
(en)
|
2014-02-10 |
2017-04-13 |
Protalix Ltd. |
Method of maintaining disease stability in a subject having gaucher's disease
|
US10564149B2
(en)
|
2014-02-11 |
2020-02-18 |
Brainstorm Cell Therapeutics Ltd. |
Populations of mesenchymal stem cells that secrete neurotrophic factors
|
EP3114483A1
(fr)
|
2014-03-03 |
2017-01-11 |
Yissum Research and Development Company of the Hebrew University of Jerusalem Ltd. |
Procédé et dispositif de détection de pseudomonas aeruginosa
|
EP2923709A1
(fr)
|
2014-03-28 |
2015-09-30 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Vaccin contre la malaria multi-composants-multi-étapes
|
US11091770B2
(en)
|
2014-04-01 |
2021-08-17 |
Monsanto Technology Llc |
Compositions and methods for controlling insect pests
|
WO2015155777A1
(fr)
|
2014-04-10 |
2015-10-15 |
Bonus Therapeutics Ltd. |
Compositions pour la réparation des os
|
CN106574296B
(zh)
|
2014-04-14 |
2021-03-02 |
耶路撒冷希伯来大学伊森姆研究发展公司 |
用于测定dna的组织或细胞来源的方法和试剂盒
|
ES2764504T3
(es)
|
2014-04-17 |
2020-06-03 |
Yeda Res & Dev |
Métodos y equipos para analizar restos de unión al ADN fijados al ADN
|
US11427647B2
(en)
|
2014-04-27 |
2022-08-30 |
Famewave Ltd. |
Polynucleotides encoding humanized antibodies against CEACAM1
|
EA037613B1
(ru)
|
2014-04-27 |
2021-04-21 |
Фэймуэйв Лтд. |
Гуманизированные антитела против ceacam1
|
ES2870658T3
(es)
|
2014-04-28 |
2021-10-27 |
Yeda Res & Dev |
Respuesta del microbioma a agentes
|
US20170071208A1
(en)
|
2014-05-04 |
2017-03-16 |
Forrest Innovations Ltd. |
Compositions for mosquito control and uses of same
|
EP3142691A4
(fr)
|
2014-05-16 |
2018-04-11 |
Baylor Research Institute |
Méthodes et compositions de traitement de maladies auto-immunes et inflammatoires
|
US10294482B2
(en)
|
2014-05-22 |
2019-05-21 |
Yeda Research And Development Co. Ltd. |
Recombinant microorganisms capable of carbon fixation
|
US20170253881A1
(en)
|
2014-06-02 |
2017-09-07 |
Technion Research & Development Foundation Limited |
Compositions and methods of selectively inhibiting irp1 and treating inflammation
|
EP3149155B1
(fr)
|
2014-06-02 |
2020-09-23 |
Kadimastem Ltd. |
Procédés d'induction de la myélinisation et de maturation des oligodendrocytes
|
CN106795515B
(zh)
|
2014-06-23 |
2021-06-08 |
孟山都技术公司 |
用于经由rna干扰调控基因表达的组合物和方法
|
WO2015198320A1
(fr)
|
2014-06-24 |
2015-12-30 |
Insight Biopharmaceuticals Ltd. |
Procédés de purification d'anticorps
|
EP3161138A4
(fr)
|
2014-06-25 |
2017-12-06 |
Monsanto Technology LLC |
Procédés et compositions pour administrer des acides nucléiques à des cellules végétales et réguler l'expression génique
|
CA2953663A1
(fr)
|
2014-06-25 |
2015-12-30 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Identification de cellules souches cancereuses et utilisation de celles-ci pour des diagnostics et traitements
|
JP2017520549A
(ja)
|
2014-06-26 |
2017-07-27 |
ラモット アット テル アビブ ユニバーシティ, リミテッド |
核酸の送達のためのリポソーム製剤
|
WO2016005985A2
(fr)
|
2014-07-09 |
2016-01-14 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Méthode pour reprogrammer des cellules
|
KR102569494B1
(ko)
|
2014-07-15 |
2023-08-21 |
이슘 리서치 디벨롭먼트 컴퍼니 오브 더 히브루 유니버시티 오브 예루살렘 엘티디. |
Cd44의 단리된 폴리펩타이드 및 이의 사용
|
EP3169407A4
(fr)
|
2014-07-15 |
2018-04-25 |
Medimmune, LLC |
Neutralisation d'anticorps anti-grippe b et leurs utilisations
|
WO2016013008A1
(fr)
|
2014-07-21 |
2016-01-28 |
Novellusdx Ltd. |
Procédés et systèmes pour déterminer un indice oncogénique de mutations spécifiques d'un patient
|
WO2016013007A1
(fr)
|
2014-07-21 |
2016-01-28 |
Novellusdx Ltd. |
Procédés de détermination d'une réponse à un médicament de mutations spécifiques à un patient
|
US10378012B2
(en)
|
2014-07-29 |
2019-08-13 |
Monsanto Technology Llc |
Compositions and methods for controlling insect pests
|
JP2017525351A
(ja)
|
2014-07-30 |
2017-09-07 |
イェダ リサーチ アンド ディベロップメント カンパニー リミテッドYeda Research And Development Co.Ltd. |
多能性幹細胞の培養用培地
|
WO2016024278A1
(fr)
|
2014-08-14 |
2016-02-18 |
Memed Diagnostics Ltd. |
Analyse computationnelle de données biologiques au moyen d'un collecteur et d'un hyperplan
|
WO2016030899A1
(fr)
|
2014-08-28 |
2016-03-03 |
Yeda Research And Development Co. Ltd. |
Méthodes de traitement de la sclérose latérale amyotrophique
|
WO2016038609A1
(fr)
|
2014-09-08 |
2016-03-17 |
Yeda Research And Development Co. Ltd. |
Anticorps anti-her3 et leurs utilisations
|
EP2992895A1
(fr)
|
2014-09-08 |
2016-03-09 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Vaccin contre la malaria multi-composants-multi-étapes
|
JP2017534574A
(ja)
|
2014-09-08 |
2017-11-24 |
イェダ リサーチ アンド ディベロップメント カンパニー リミテッドYeda Research And Development Co.Ltd. |
チロシンキナーゼ阻害薬(tki)に耐性のがんを処置するための組成物および方法
|
IL234638A0
(en)
|
2014-09-14 |
2014-12-02 |
Yeda Res & Dev |
NMDA receptor antagonists for the treatment of Gaucher disease
|
CN106999608A
(zh)
|
2014-09-21 |
2017-08-01 |
耶路撒冷希伯来大学伊森姆研究发展公司 |
为了治疗脂质相关病症而下调mir‑132
|
US20170296650A1
(en)
|
2014-10-08 |
2017-10-19 |
Novartis Ag |
Combination of human cytomegalovirus neutralizing antibodies
|
GB2555995B
(en)
|
2014-10-20 |
2019-06-26 |
Gen Probe Inc |
Red blood cell lysis solution
|
CN107406825B
(zh)
|
2014-11-13 |
2022-04-08 |
恩祖迪克控股有限公司 |
甲壳纲十足目雌性动物的功能性别反转
|
WO2016075546A2
(fr)
|
2014-11-14 |
2016-05-19 |
Antonio Lanzavecchia |
Anticorps qui neutralisent le virus ebola et leurs utilisations
|
WO2016079731A2
(fr)
|
2014-11-17 |
2016-05-26 |
Yeda Research And Development Co. Ltd. |
Procédé d'analyse de microbiome
|
WO2016079736A2
(fr)
|
2014-11-17 |
2016-05-26 |
Yeda Research And Development Co. Ltd. |
Procédés de traitement de maladies associées à une fonction mitochondriale
|
EP3220947B1
(fr)
|
2014-11-18 |
2020-10-28 |
Humabs Biomed S.A. |
Anticorps à puissante activité de neutralisation du virus de la rage et d'autres lyssavirus et leurs utilisations
|
WO2016079739A2
(fr)
|
2014-11-20 |
2016-05-26 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Compositions et procédés de production de polypeptides présentant un schéma de glycosylation modifié dans des cellules végétales
|
CN107208070B
(zh)
|
2014-11-26 |
2021-09-07 |
技术创新动力基金(以色列)有限合伙公司 |
细菌基因的靶向消除
|
WO2016084084A1
(fr)
|
2014-11-27 |
2016-06-02 |
Danziger Innovations Ltd. |
Construction d'acide nucléique pour l'édition de génome
|
WO2016092555A2
(fr)
|
2014-12-11 |
2016-06-16 |
Yeda Research And Development Co. Ltd. |
Polypeptides de phosphotriestérase isolés, polynucléotides codant pour ceux-ci et utilisations de ceux-ci dans le traitement ou la prévention des dommages associés à l'exposition aux organophosphates
|
WO2016103269A1
(fr)
|
2014-12-23 |
2016-06-30 |
Ramot At Tel-Aviv University Ltd. |
Populations de cellules progénitrices neuronales et leurs procédés de production et d'utilisation
|
JP6882981B2
(ja)
|
2014-12-30 |
2021-06-02 |
セル キュア ニューロサイエンシズ リミテッド |
Rpe細胞集団およびそれを作製する方法
|
EP3240612B1
(fr)
|
2014-12-30 |
2020-12-23 |
Cell Cure Neurosciences Ltd. |
Procédés de traitement de maladies rétiniennes
|
JP2018502575A
(ja)
|
2014-12-30 |
2018-02-01 |
セル キュア ニューロサイエンシズ リミテッド |
網膜色素上皮細胞集団の評価法
|
RU2017125957A
(ru)
|
2015-01-04 |
2019-02-04 |
Проталикс Лтд. |
Модифицированная днказа и ее применения
|
WO2016116935A1
(fr)
|
2015-01-21 |
2016-07-28 |
Yeda Research And Development Co. Ltd. |
Utilisation de la rasa2 en tant que marqueur pronostique et thérapeutique pour un mélanome
|
CN108064288B
(zh)
|
2015-01-22 |
2021-11-26 |
孟山都技术公司 |
用于控制叶甲属的组合物和方法
|
WO2016135732A1
(fr)
|
2015-02-26 |
2016-09-01 |
Yeda Research And Development Co. Ltd. |
Procédé favorisant la pousse des cheveux
|
WO2016142948A1
(fr)
|
2015-03-11 |
2016-09-15 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Oligonucléotides leurres pour le traitement de maladies
|
IL237852A0
(en)
|
2015-03-19 |
2016-03-24 |
Yeda Res & Dev |
Antibodies against amphigoline, medical preparations containing them and their use
|
AU2016243124A1
(en)
|
2015-03-27 |
2017-11-02 |
University Of Southern California |
CAR T-cell therapy directed to LHR for the treatment of solid tumors
|
EP4218771A1
(fr)
|
2015-03-27 |
2023-08-02 |
Yeda Research and Development Co. Ltd |
Méthodes de traitement des maladies des motoneureones
|
CA2979309A1
(fr)
|
2015-03-31 |
2016-10-06 |
Yeda Research And Development Co. Ltd. |
Glutamate oxaloacetate transaminase 1 (got1), preparations, procedes de generation des preparations et utilisations des preparations
|
EP3277260B1
(fr)
|
2015-04-01 |
2021-05-12 |
The State of Israel, Ministry of Agriculture & Rural Development, Agricultural Research Organization (ARO) (Volcani Center) |
Extraits végétaux de crassifolium erodium l'her et leurs utilisations
|
HUE057044T2
(hu)
|
2015-04-07 |
2022-04-28 |
Ela Pharma Ltd |
Sejt- vagy szövetnekrózis kezelésére és/vagy megelõzésére szolgáló, katepszin C-t és/vagy CELA1-et és/vagy CELA3A-t és/vagy szerkezetileg rokon enzimeket specifikusan targetáló készítmények
|
EP3081575A1
(fr)
|
2015-04-12 |
2016-10-19 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Anticorps anti-plasmodium pour parasite
|
AU2016255725B2
(en)
|
2015-04-27 |
2021-09-23 |
The Medical Research, Infrastructure and Health Services Fund of the Tel Aviv Medical Center |
EGR1 targeting molecules for the treatment of inflammatory and hyperproliferative conditions
|
EP3288386B1
(fr)
|
2015-04-29 |
2022-01-19 |
The State of Israel, Ministry of Agriculture & Rural Development, Agricultural Research Organization (ARO) (Volcani Center) |
Compositions anti-phytopathogènes
|
WO2016174652A1
(fr)
|
2015-04-30 |
2016-11-03 |
Technion Research & Development Foundation Limited |
Récepteurs antigéniques chimériques et méthodes d'utilisation correspondantes
|
WO2016178207A1
(fr)
|
2015-05-04 |
2016-11-10 |
Ramot At Tel-Aviv University Ltd. |
Procédés et kits pour fragmenter l'adn
|
WO2016181393A1
(fr)
|
2015-05-11 |
2016-11-17 |
Yeda Research And Development Co. Ltd. |
Inhibiteurs de citrine pour le traitement du cancer
|
US11219636B2
(en)
|
2015-05-17 |
2022-01-11 |
The Medical Research, Infrastructure and Health Services Fund of the Tel Aviv Medical Center |
Compositions and methods for treating cancer
|
WO2016185457A1
(fr)
|
2015-05-19 |
2016-11-24 |
Yeda Research And Development Co. Ltd. |
Méthodes pour favoriser la lymphagiogenèse
|
US10849985B2
(en)
|
2015-05-20 |
2020-12-01 |
Yeda Research And Development Co. Ltd. |
Method of targeting senescent cells
|
CA2986203A1
(fr)
|
2015-05-21 |
2016-11-24 |
Yeda Research And Development Co. Ltd. |
Populations bacteriennes pour favoriser la sante
|
EP3302571B1
(fr)
|
2015-05-29 |
2020-11-18 |
OPKO Biologics Ltd. |
Variantes de l'oxyntomoduline pégylée
|
CN107667114B
(zh)
|
2015-06-01 |
2021-07-02 |
免疫医疗有限责任公司 |
中和抗流感结合分子及其用途
|
EP3302053B1
(fr)
|
2015-06-02 |
2021-03-17 |
Monsanto Technology LLC |
Compositions et procédés pour l'administration d'un polynucléotide dans une plante
|
WO2016196782A1
(fr)
|
2015-06-03 |
2016-12-08 |
Monsanto Technology Llc |
Procédés et compositions pour l'introduction d'acides nucléiques dans des plantes
|
EP3302559B1
(fr)
|
2015-06-04 |
2022-01-12 |
University of Southern California |
Immunothérapie des cellules car ciblées par lym-1 et lym-2
|
NL2014935B1
(en)
|
2015-06-08 |
2017-02-03 |
Applied Immune Tech Ltd |
T cell receptor like antibodies having fine specificity.
|
WO2016203476A1
(fr)
|
2015-06-18 |
2016-12-22 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Procédés et compositions pour le diagnostic et le traitement d'un cancer urothélial
|
EP4026563A1
(fr)
|
2015-06-18 |
2022-07-13 |
Yeda Research and Development Co. Ltd |
Protocoles de conditionnement et utilisation de ceux-ci pour la régénération de tissu
|
CN113289009A
(zh)
|
2015-06-19 |
2021-08-24 |
Opko生物科学有限公司 |
长效凝固因子及其产生方法
|
EP3313871A1
(fr)
|
2015-06-26 |
2018-05-02 |
Institute for Research in Biomedicine |
Protéines comprenant un fragment lair-1 muté et leurs utilisations
|
AU2016291817A1
(en)
|
2015-07-16 |
2018-02-22 |
Biolinerx Ltd. |
Compositions and methods for treating cancer
|
CN114457039A
(zh)
|
2015-07-16 |
2022-05-10 |
耶达研究及发展有限公司 |
基因修饰的抗第三方中央型记忆t细胞及其在免疫疗法中的用途
|
WO2017013648A1
(fr)
|
2015-07-19 |
2017-01-26 |
Yeda Research And Development Co. Ltd. |
Inhibiteurs sélectifs des isoformes contenant alpha2 de la na,k-atpase et leur utilisation pour réduire la pression intraoculaire
|
MX2018000844A
(es)
|
2015-07-22 |
2018-07-06 |
Phytopharma Int Ltd |
Composiciones ingeribles por abejas, procedimientos para el uso de las mismas para producir miel y miel producida de esta manera.
|
WO2017017686A1
(fr)
|
2015-07-29 |
2017-02-02 |
Hadasit Medical Research Services And Development Ltd. |
Production à grande échelle de cellules de l'épithélium pigmentaire rétinien
|
ES2965461T3
(es)
|
2015-08-03 |
2024-04-15 |
Biokine Therapeutics Ltd |
Inhibidor de CXCR4 para el tratamiento del cáncer
|
EP3332009A1
(fr)
|
2015-08-04 |
2018-06-13 |
Yeda Research and Development Co., Ltd. |
Procédés de criblage pour riborégulateurs et atténuateurs
|
EP4155391A1
(fr)
|
2015-08-05 |
2023-03-29 |
Cell Cure Neurosciences Ltd. |
Préparation de cellules de l'épithélium pigmentaire rétinien
|
EP3331995A1
(fr)
|
2015-08-05 |
2018-06-13 |
Cell Cure Neurosciences Ltd. |
Préparation de photorécepteurs pour le traitement de maladies rétiniennes
|
EP3334449B1
(fr)
|
2015-08-10 |
2021-09-29 |
The Medical Research, Infrastructure, And Health Services Fund Of The Tel Aviv Medical Center |
Méthodes et compositions pharmaceutiques permettant d'améliorer la cicatrisation des plaies par cd24
|
EP3334831A1
(fr)
|
2015-08-13 |
2018-06-20 |
Forrest Innovations Ltd. |
Formulations et compositions d'administration d'acides nucléiques à des cellules végétales
|
WO2017033188A1
(fr)
|
2015-08-24 |
2017-03-02 |
Yeda Research And Development Co. Ltd. |
Huile et biocarburant d'origine algale et leurs procédés de production
|
US10765706B2
(en)
|
2015-09-03 |
2020-09-08 |
University Of South Florida |
Method of stem cell delivery into the brain during chronic disease using blood brain barrier permeabilizers
|
WO2017042816A1
(fr)
|
2015-09-10 |
2017-03-16 |
Yeda Research And Development Co. Ltd. |
Ablation de cellules dendritiques dont le test est positif pour la perforine, dans le traitement du cancer
|
WO2017059878A1
(fr)
|
2015-10-07 |
2017-04-13 |
Humabs Biomed Sa |
Anticorps neutralisant puissamment le virus de l'hépatite b et utilisations de ces derniers
|
WO2017072757A1
(fr)
|
2015-10-25 |
2017-05-04 |
Yeda Research And Development Co. Ltd. |
Anticorps ciblant la quiescine sulfhydryle oxydase (qsox1) et leurs utilisations
|
AU2016347652A1
(en)
|
2015-10-26 |
2018-05-24 |
Cell Cure Neurosciences Ltd. |
Preparation of retinal pigment epithelium cells
|
CA3187317A1
(fr)
|
2015-10-27 |
2017-05-04 |
Jay Pharma, Inc. |
Compositions comprenant du cannabidiol et un des seconds agents therapeutiques pour le traitement du cancer
|
IL242380A0
(en)
|
2015-10-29 |
2016-02-01 |
Yeda Res & Dev |
A method for inducing the division of cardiomyocytes and treating heart diseases
|
WO2017077539A1
(fr)
|
2015-11-03 |
2017-05-11 |
Ariel-University Research And Development Company Ltd. |
Compositions destinées à la régénération et à la réparation de tissu nerveux
|
EP3374524A4
(fr)
|
2015-11-11 |
2019-06-26 |
Ramot at Tel-Aviv University Ltd. |
Procédés de détection de la 5-hydroxyméthylcytosine et diagnostic du cancer
|
WO2017094001A1
(fr)
|
2015-11-30 |
2017-06-08 |
Kadimastem Ltd |
Procédés de différenciation et de purification de cellules endocrines pancréatiques
|
EP3176183A1
(fr)
|
2015-12-02 |
2017-06-07 |
Yeda Research and Development Co. Ltd |
Compositions et procédés pour traiter un cancer non résistant à un inhibiteur de la tyrosine kinase (tki)
|
ES2924732T3
(es)
|
2015-12-16 |
2022-10-10 |
Univ Ramot |
Partículas que comprenden epiplón descelularizado
|
IL260331B1
(en)
|
2015-12-28 |
2024-06-01 |
B G Negev Technologies And Applications Ltd At Ben Gurion Univ |
Compounds and methods for the treatment of amyotrophic lateral sclerosis
|
EP3400068A1
(fr)
|
2016-01-06 |
2018-11-14 |
Yeda Research and Development Co., Ltd. |
Compositions et méthodes pour le traitement d'affections malignes, autoimmunes et inflammatoires
|
WO2017122203A1
(fr)
|
2016-01-11 |
2017-07-20 |
Technion Research & Development Foundation Limited |
Méthodes de détermination du pronostic de septicémie et traitement associé
|
IL260413B2
(en)
|
2016-01-13 |
2024-01-01 |
Medimmune Llc |
A method for treating type A influenza
|
WO2017125931A1
(fr)
|
2016-01-21 |
2017-07-27 |
The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization (Aro) (Volcani Center) |
Plantes parthénocarpiques et procédés de production de celles-ci
|
IL243838A
(en)
|
2016-01-28 |
2017-07-31 |
Sp Nano Ltd |
The composition containing sp1 protein and carbon nanoparticles and its uses
|
IL243839B
(en)
|
2016-01-28 |
2018-01-31 |
Sp Nano Ltd |
Conductive wires
|
WO2017130205A1
(fr)
|
2016-01-31 |
2017-08-03 |
Hadasit Medical Research Services And Development Ltd. |
Populations de cellules souches pluripotentes ayant une composition de chromosomes sexuels non identiques et leurs utilisations
|
WO2017134671A1
(fr)
|
2016-02-04 |
2017-08-10 |
Yeda Research And Development Co. Ltd. |
Peptides et leur utilisation dans le traitement de maladies, troubles ou affections associés à un p53 mutant
|
ES2771223T3
(es)
|
2016-02-14 |
2020-07-06 |
Yeda Res & Dev |
Diagnóstico, predicción y tratamiento de la obesidad recidivante basados en el microbioma
|
WO2017138008A2
(fr)
|
2016-02-14 |
2017-08-17 |
Yeda Research And Development Co. Ltd. |
Procédés de modulation de l'exocytose de protéines et utilisations associées en thérapie
|
MX2018009984A
(es)
|
2016-02-16 |
2019-01-21 |
Yissum Res Dev Co Of Hebrew Univ Jerusalem Ltd |
Análogos no proteínicos de fenilananina para la inhibicion del crecimiento de cianobacterias y plantas.
|
JP2019511919A
(ja)
|
2016-02-23 |
2019-05-09 |
ブローディ,チャヤ |
がん幹細胞の作製およびその使用
|
IL296874A
(en)
|
2016-03-01 |
2022-11-01 |
Yissum Res Dev Co Of Hebrew Univ Jerusalem Ltd |
Antibodies specific for the human poliovirus receptor
|
WO2017149547A1
(fr)
|
2016-03-03 |
2017-09-08 |
Memed Diagnostics Ltd. |
Analyse d'arn pour diagnostiquer un type d'infection
|
US20190216891A1
(en)
|
2016-03-06 |
2019-07-18 |
Yeda Research And Development Co., Ltd. |
Method for modulating myelination
|
IL244649A0
(en)
|
2016-03-17 |
2016-06-30 |
Yeda Res & Dev |
Methods for the isolation of barrel-like proteases and the identification of peptides that are cleaved by Alidan
|
US10421785B2
(en)
|
2016-04-11 |
2019-09-24 |
Bar-Ilan University |
Delta receptor agonist peptides and use thereof
|
DE202017007130U1
(de)
|
2016-04-27 |
2019-08-29 |
Gen-Probe Inc. |
Lysereagenz für Blutzellen
|
ES2886627T3
(es)
|
2016-05-22 |
2021-12-20 |
Yeda Res & Dev |
Métodos de uso de células pulmonares para trasplante e inducción de tolerancia
|
IL245861A0
(en)
|
2016-05-25 |
2016-09-04 |
Yeda Res & Dev |
Use of substances to treat drug-resistant tumors
|
US20190100732A1
(en)
|
2016-06-02 |
2019-04-04 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Assay for the removal of methyl-cytosine residues from dna
|
EP3464322B1
(fr)
|
2016-06-05 |
2023-04-05 |
Tel HaShomer Medical Research Infrastructure and Services Ltd. |
Nouvelles molécules destinées au traitement de l'inflammation
|
US20190160152A1
(en)
|
2016-06-09 |
2019-05-30 |
Opko Biologics Ltd. |
Long-acting oxyntomodulin formulation and methods of producing and administering same
|
EP3472342A1
(fr)
|
2016-06-19 |
2019-04-24 |
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. |
Criblage de la résistance à la chimiothérapie dans des cellules haploïdes humaines
|
JP7334043B2
(ja)
|
2016-06-27 |
2023-08-28 |
イェダ リサーチ アンド ディベロップメント カンパニー リミテッド |
メモリーt細胞から作られるベト細胞
|
EP4184167A1
(fr)
|
2016-07-10 |
2023-05-24 |
MeMed Diagnostics Ltd. |
Diagnostic précoce d'infections
|
CN109661578B
(zh)
|
2016-07-10 |
2022-05-10 |
米密德诊断学有限公司 |
用于区分细菌和病毒感染的蛋白质特征
|
IL246722A0
(en)
|
2016-07-11 |
2016-09-29 |
Yeda Res & Dev |
Combined treatment to increase endogenous synthesis of nitric oxide
|
IL291373B2
(en)
|
2016-07-11 |
2023-10-01 |
Yissum Res Dev Co Of Hebrew Univ Jerusalem Ltd |
Methods and systems for growing cells in culture
|
CN109689893A
(zh)
|
2016-07-11 |
2019-04-26 |
博纳斯治疗公司 |
用于组织再生的细胞组合物
|
CN118085104A
(zh)
|
2016-07-11 |
2024-05-28 |
Opko生物科学有限公司 |
长效凝血因子及其制备方法
|
WO2018010789A1
(fr)
|
2016-07-13 |
2018-01-18 |
Humabs Biomed Sa |
Nouveaux anticorps se liant spécifiquement aux épitopes du virus zika et leurs utilisations
|
EP4434516A2
(fr)
|
2016-07-18 |
2024-09-25 |
Ramot at Tel-Aviv University Ltd. |
Plate-forme modulaire pour agents thérapeutiques ciblés
|
WO2018020489A1
(fr)
|
2016-07-24 |
2018-02-01 |
Yeda Research And Development Co. Ltd. |
Méthodes et kits pour analyser des fragments de liaison à l'adn liés à l'adn
|
US10982252B2
(en)
|
2016-08-08 |
2021-04-20 |
Technology Innovation Momentum Fund (Israel) Limited Partnership |
Bacterial systems for analyzing ubiquitylated polypeptides
|
EP3497239A4
(fr)
|
2016-08-10 |
2020-02-26 |
Ramot at Tel-Aviv University Ltd. |
Analyse de l'état de méthylation et du nombre de copies
|
EP4033248B1
(fr)
|
2016-08-10 |
2024-04-10 |
MeMed Diagnostics Ltd. |
Système et procédé d'analyse de mx1 et crp dans le sang
|
IL264825B
(en)
|
2016-08-14 |
2022-08-01 |
Univ Ramot |
Exosomes from mesenchymal cells for the treatment of neurological diseases
|
IL247368A0
(en)
|
2016-08-18 |
2016-11-30 |
Yeda Res & Dev |
Diagnostic and therapeutic uses of exosomes
|
WO2018037416A1
(fr)
|
2016-08-25 |
2018-03-01 |
Yeda Research And Development Co. Ltd. |
Procédés et compositions pour le traitement de maladies auto-immunes
|
EP3510047A1
(fr)
|
2016-09-07 |
2019-07-17 |
Yissum Research and Development Company of the Hebrew University of Jerusalem Ltd. |
Anticorps anti-nkp46 et leur utilisation thérapeutique
|
US11485971B2
(en)
|
2016-09-14 |
2022-11-01 |
Yeda Research And Development Co. Ltd. |
CRISP-seq, an integrated method for massively parallel single cell RNA-seq and CRISPR pooled screens
|
WO2018060998A1
(fr)
|
2016-09-29 |
2018-04-05 |
Memed Diagnostics Ltd. |
Méthodes de pronostic et de traitement
|
IL248468A0
(en)
|
2016-10-13 |
2017-01-31 |
Technion Res & Dev Foundation |
Use of caspase-3 inhibitors and caspase-3 activators in the preparation of medical preparations for cancer treatment and wound healing
|
IL248385A0
(en)
|
2016-10-18 |
2017-02-01 |
Yeda Res & Dev |
Treatment of circadian rhythm disorder
|
US10662226B2
(en)
|
2016-10-28 |
2020-05-26 |
The Regents of the University of Caiifomia |
Synthetic beta-amyloid peptides capable of forming stable antigenic oligomers
|
US20190359956A1
(en)
|
2016-11-10 |
2019-11-28 |
Yeda Research And Development Co. Ltd. |
Phosphotriesterases for treating or preventing organophosphate exposure associated damage
|
US11542508B2
(en)
|
2016-11-28 |
2023-01-03 |
Yeda Research And Development Co. Ltd. |
Isolated polynucleotides and polypeptides and methods of using same for expressing an expression product of interest
|
EP3548015A1
(fr)
|
2016-11-30 |
2019-10-09 |
Yeda Research and Development Co. Ltd. |
Méthodes de traitement de maladies et de la toxicité hépathique
|
EP3548106B1
(fr)
|
2016-12-01 |
2023-01-04 |
Ramot at Tel-Aviv University Ltd. |
Traitement combiné pour lésions nerveuses
|
EP3571295A1
(fr)
|
2017-01-18 |
2019-11-27 |
Yeda Research and Development Co. Ltd |
Cellules veto génétiquement modifiées et leur utilisation en immunothérapie
|
IL250479A0
(en)
|
2017-02-06 |
2017-03-30 |
Sorek Rotem |
Genetically engineered cells expressing a disarm system that confers resistance to phages and methods for their production
|
IL250916A0
(en)
|
2017-03-02 |
2017-06-29 |
Geiger Benjamin |
Methods for growing t cells in culture and their use
|
WO2018167780A1
(fr)
|
2017-03-12 |
2018-09-20 |
Yeda Research And Development Co. Ltd. |
Méthodes de diagnostic et de traitement du cancer
|
EP3596469A1
(fr)
|
2017-03-12 |
2020-01-22 |
Yeda Research and Development Co., Ltd. |
Procédés de diagnostic et de pronostic du cancer
|
IL269363B2
(en)
|
2017-03-16 |
2024-02-01 |
Lineage Cell Therapeutics Inc |
Methods for measuring medical effects of treating retinal diseases
|
FI3607050T3
(fi)
|
2017-04-05 |
2023-11-20 |
Yeda Res & Dev |
Ex vivo viljelyjärjestelmä ja menetelmiä sen käyttämiseksi
|
BR112019021824A2
(pt)
|
2017-04-19 |
2020-06-02 |
Institute For Research In Biomedicine |
Vacinas contra a malária e anticorpos de ligação a esporozoítos de plasmódio
|
IL252151A0
(en)
|
2017-05-07 |
2017-07-31 |
Fainzilber Michael |
Treatment of stress disorders
|
US12091445B2
(en)
|
2017-05-10 |
2024-09-17 |
Ariel Scientific Innovations Ltd. |
Methods of purifying antibodies
|
ES2939298T3
(es)
|
2017-05-21 |
2023-04-20 |
Medical Res Infrastructure & Health Services Fund Tel Aviv Medical Ct |
Combinación de marcadores para el diagnóstico del cáncer
|
WO2018216011A1
(fr)
|
2017-05-23 |
2018-11-29 |
Technion Research & Development Foundation Limited |
Agents inhibant la dimérisation de gads et leurs procédés d'utilisation
|
GB201708662D0
(en)
|
2017-05-31 |
2017-07-12 |
Tropic Biosciences Uk Ltd |
Compositions and methods for increasing shelf-life of banana
|
GB201708665D0
(en)
|
2017-05-31 |
2017-07-12 |
Tropic Biosciences Uk Ltd |
Compositions and methods for increasing extractability of solids from coffee beans
|
WO2018220582A1
(fr)
|
2017-05-31 |
2018-12-06 |
Tropic Biosciences UK Limited |
Méthodes de sélection de cellules comprenant des événements d'édition de génome
|
WO2018229764A1
(fr)
|
2017-06-13 |
2018-12-20 |
Yeda Research And Development Co. Ltd. |
Traitement de la sclérose en plaques avancée ou progressive
|
EP3652344A1
(fr)
|
2017-07-13 |
2020-05-20 |
Yissum Research and Development Company of the Hebrew University of Jerusalem Ltd. |
Cibles d'adn à titre de marqueurs de méthylation spécifiques de tissu
|
EP3652343A1
(fr)
|
2017-07-13 |
2020-05-20 |
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. |
Stratégie de pcr en gouttelettes à double sonde pour la détection spécifique de molécules d'adn circulantes spécifiques d'un tissu
|
EP3652342A1
(fr)
|
2017-07-13 |
2020-05-20 |
Yissum Research and Development Company of the Hebrew University of Jerusalem Ltd. |
Détection d'adn spécifique d'un tissu
|
IL253642A0
(en)
|
2017-07-24 |
2017-09-28 |
Seger Rony |
Combined treatment for cancer
|
IL253984A0
(en)
|
2017-08-14 |
2017-09-28 |
Yeda Res & Dev |
Immunotherapy against aranviruses that bind through transferrin receptor 1 (tfr1
|
US11692166B2
(en)
|
2017-08-23 |
2023-07-04 |
Technion Research & Development Foundation Limited |
Compositions and methods for improving alcohol tolerance in yeast
|
WO2019042555A1
(fr)
|
2017-08-31 |
2019-03-07 |
Humabs Biomed Sa |
Anticorps multispécifiques se liant spécifiquement aux épitopes du virus zika et leurs utilisations
|
EP3684929A1
(fr)
|
2017-09-19 |
2020-07-29 |
Tropic Biosciences UK Limited |
Modification de la spécificité de molécules d'arn non codantes pour le silençage de l'expression génique dans des cellules eucaryotes
|
AU2018364630A1
(en)
|
2017-11-09 |
2020-05-21 |
Pinteon Therapeutics Inc. |
Methods and compositions for the generation and use of humanized conformation-specific phosphorylated tau antibodies
|
IL255664A0
(en)
|
2017-11-14 |
2017-12-31 |
Shachar Idit |
Hematopoietic stem cells with enhanced properties
|
EP3717032B1
(fr)
|
2017-11-29 |
2023-02-15 |
Ramot at Tel-Aviv University Ltd. |
Procédés de traitement prophylactique ou thérapeutique de choc neurogénique
|
WO2019106667A1
(fr)
|
2017-11-29 |
2019-06-06 |
Weedout Ltd. |
Compositions, kits et procédés de lutte contre les mauvaises herbes du genre amaranthus
|
WO2019106680A1
(fr)
|
2017-12-03 |
2019-06-06 |
Yeda Research And Development Co. Ltd. |
Traitement d'une maladie cardiaque ischémique
|
EP3723785A1
(fr)
|
2017-12-17 |
2020-10-21 |
Yeda Research and Development Co. Ltd |
Modulateurs du complexe signalosome cop9 (csn) et leurs utilisations
|
WO2019130313A1
(fr)
|
2017-12-28 |
2019-07-04 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Procédé pour reproduire des rythmes circadiens sur une puce microfluidique
|
IL257225A
(en)
|
2018-01-29 |
2018-04-09 |
Yeda Res & Dev |
Treatment of sarcoma
|
IL257269A
(en)
|
2018-01-31 |
2018-04-09 |
Olender Tsviya |
Signaling is directed to the endoplasmic reticulum
|
WO2019155459A1
(fr)
|
2018-02-08 |
2019-08-15 |
Yeda Research And Development Co. Ltd. |
Inhibiteurs du protéasome 20s
|
WO2019155465A1
(fr)
|
2018-02-08 |
2019-08-15 |
Yeda Research And Development Co. Ltd. |
Procédés d'identification et d'utilisation d'agents pour traiter des maladies associées à un dysfonctionnement de la barrière intestinale
|
WO2019162945A1
(fr)
|
2018-02-23 |
2019-08-29 |
Carmel Haifa University Economic Corporation Ltd. |
Méthodes de traitement d'un trouble de la mémoire et d'un dysfonctionnement cognitif
|
US20200408761A1
(en)
|
2018-02-28 |
2020-12-31 |
The Medical Research, Infrastructure and Health Services Fund of the Tel Aviv Medical Center |
Methods of diagnosing and treating bladder cancer
|
WO2019175869A1
(fr)
|
2018-03-12 |
2019-09-19 |
Yeda Research And Development Co. Ltd |
Traitement d'une maladie cardiaque
|
US11413336B2
(en)
|
2018-03-23 |
2022-08-16 |
Board Of Regents, The University Of Texas System |
Coccidioides antigens and methods of their use
|
WO2019186558A1
(fr)
|
2018-03-29 |
2019-10-03 |
Technion Research And Development Foundation Limited |
Vésicules comprenant un inhibiteur de pten et leurs utilisations
|
EP3774047A1
(fr)
|
2018-03-29 |
2021-02-17 |
Yeda Research and Development Co. Ltd |
Utilisation de gradients de champ électrique pour commander l'expression génique
|
IL258467A
(en)
|
2018-03-29 |
2018-07-04 |
Ilana Kolodkin Gal |
Methods of disrupting a biofilm and/or preventing formation of same
|
GB201807192D0
(en)
|
2018-05-01 |
2018-06-13 |
Tropic Biosciences Uk Ltd |
Compositions and methods for reducing caffeine content in coffee beans
|
IL259392A
(en)
|
2018-05-15 |
2018-08-01 |
Yeda Res & Dev |
Vaccination with cancer neo-antigens
|
WO2019220441A1
(fr)
|
2018-05-15 |
2019-11-21 |
Hadasit Medical Research Services And Development Ltd. |
Compositions et méthodes de traitement du cancer résistant à un agent anticancéreux
|
US20210121491A1
(en)
|
2018-05-27 |
2021-04-29 |
Biolinerx Ltd. |
Agi-134 combined with a checkpoint inhibitor for the treatment of solid tumors
|
US11827892B2
(en)
|
2018-06-07 |
2023-11-28 |
The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization (Aro) (Volcani Center) |
Nucleic acid constructs and methods of using same
|
CA3102975A1
(fr)
|
2018-06-07 |
2019-12-12 |
The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization (Aro) (Volcani Center) |
Procedes de regeneration et de transformation de cannabis
|
US11873322B2
(en)
|
2018-06-25 |
2024-01-16 |
Yeda Research And Development Co. Ltd. |
Systems and methods for increasing efficiency of genome editing
|
AU2019297677A1
(en)
|
2018-07-04 |
2021-02-25 |
Ukko Inc. |
Methods of de-epitoping wheat proteins and use of same for the treatment of celiac disease
|
US20210269860A1
(en)
|
2018-07-08 |
2021-09-02 |
Yeda Research And Development Co. Ltd. |
Person-specific assessment of probiotics responsiveness
|
EP3814385A4
(fr)
|
2018-07-11 |
2022-04-06 |
KAHR Medical Ltd. |
Protéine de fusion du variant de sirpalpha-4-1bbl et procédés d'utilisation associés
|
CN112351989B
(zh)
|
2018-07-11 |
2024-03-26 |
免疫制药有限公司 |
肽化合物及其治疗用途
|
JP7479343B2
(ja)
|
2018-07-31 |
2024-05-08 |
コルプラント リミテッド |
タバコのトランスジェニックイベント、並びにその検出方法およびその使用
|
IL261156A
(en)
|
2018-08-14 |
2020-02-27 |
Fass Deborah |
Chimeric quiescin sulfhydryl oxidase (qsox1) antibodies and uses of same
|
US11548938B2
(en)
|
2018-08-21 |
2023-01-10 |
Quidel Corporation |
DbpA antibodies and uses thereof
|
WO2020039440A1
(fr)
|
2018-08-24 |
2020-02-27 |
Yeda Research And Development Co. Ltd. |
Procédés de modulation de la polarisation de macrophages m2 et leur utilisation en thérapie
|
CN113038951B
(zh)
|
2018-09-20 |
2024-04-30 |
耶达研究及发展有限公司 |
治疗肌萎缩侧索硬化的方法
|
US20210338767A1
(en)
|
2018-09-25 |
2021-11-04 |
Biolinerx Ltd. |
Methods of selecting treatment for cxcr4-associated cancer
|
IL262658A
(en)
|
2018-10-28 |
2020-04-30 |
Memorial Sloan Kettering Cancer Center |
Prevention of age related clonal hematopoiesis and diseases associated therewith
|
IL263184A
(en)
|
2018-11-21 |
2020-05-31 |
Yarden Yosef |
Method of treating cancer and compositions for same
|
AU2019403245A1
(en)
|
2018-12-19 |
2021-07-22 |
Humabs Biomed Sa |
Antibodies that neutralize hepatitis B virus and uses thereof
|
EP3914698A1
(fr)
|
2019-01-23 |
2021-12-01 |
Yeda Research and Development Co. Ltd |
Milieux de culture pour cellules souches pluripotentes
|
IL264768A
(en)
|
2019-02-10 |
2020-08-31 |
Sagi Irit |
ANTI-MATRIX METALLOPROTEINASE 7 (MMP-7) inhibitory antibody and its use
|
IL264854A
(en)
|
2019-02-14 |
2020-08-31 |
Bahat Anat |
Spt5 inhibitors and methods of use thereof
|
EP3927807A1
(fr)
|
2019-02-21 |
2021-12-29 |
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. |
Procédés de génération d'organoïdes pour criblage à haut rendement de médicaments
|
WO2020170240A1
(fr)
|
2019-02-21 |
2020-08-27 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Procédé de réduction d'une néphrotoxicité induite par des médicaments
|
WO2020178822A1
(fr)
|
2019-03-05 |
2020-09-10 |
The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization (Aro) (Volcani Center) |
Oiseaux à édition de génome
|
GB201903519D0
(en)
|
2019-03-14 |
2019-05-01 |
Tropic Biosciences Uk Ltd |
Introducing silencing activity to dysfunctional rna molecules and modifying their specificity against a gene of interest
|
GB201903520D0
(en)
|
2019-03-14 |
2019-05-01 |
Tropic Biosciences Uk Ltd |
Modifying the specificity of non-coding rna molecules for silencing genes in eukaryotic cells
|
GB201903521D0
(en)
|
2019-03-14 |
2019-05-01 |
Tropic Biosciences Uk Ltd |
No title
|
IL265486A
(en)
|
2019-03-19 |
2020-09-30 |
Yeda Res & Dev |
Bistable type ii opsins and uses thereof
|
JP2022527506A
(ja)
|
2019-03-27 |
2022-06-02 |
アンセルム(アンスティチュート・ナシオナル・ドゥ・ラ・サンテ・エ・ドゥ・ラ・ルシェルシュ・メディカル) |
Cd40活性化特性を有する組換えタンパク質
|
WO2020194317A1
(fr)
|
2019-03-28 |
2020-10-01 |
Yeda Research And Development Co. Ltd. |
Méthode de traitement de troubles liés aux lipides
|
WO2020202142A2
(fr)
|
2019-03-31 |
2020-10-08 |
Yeda Research And Development Co. Ltd. |
Composés anti-viraux et anti-tumoraux
|
IL266433B
(en)
|
2019-05-02 |
2020-11-30 |
Sagi Irit |
Compositions comprising the propeptide of lysyl oxidase and uses thereof
|
US20220220559A1
(en)
|
2019-05-13 |
2022-07-14 |
Yeda Research And Development Co. Ltd. |
Cell-free mirna biomarkers for prognosis and diagnosis of neurodegenerative diseases
|
IL266728B
(en)
|
2019-05-19 |
2020-11-30 |
Yeda Res & Dev |
Identification of recurrent mutant neopeptides
|
WO2020234888A1
(fr)
|
2019-05-22 |
2020-11-26 |
Hadasit Medical Research Services And Development Ltd. |
Procédés de culture de cellules pluripotentes humaines
|
CN114599675B
(zh)
|
2019-05-28 |
2024-08-16 |
上海科技大学 |
用于治疗clouston型外胚层发育不良2的组合物和方法
|
EP3983531A1
(fr)
|
2019-06-12 |
2022-04-20 |
Hadasit Medical Research Services and Development Ltd. |
Procédés de génération d'oligodendrocytes
|
WO2020255124A1
(fr)
|
2019-06-16 |
2020-12-24 |
Yeda Research And Development Co. Ltd. |
Méthode de stabilisation de l'arn intracellulaire
|
WO2020261281A1
(fr)
|
2019-06-27 |
2020-12-30 |
Ramot At Tel-Aviv University Ltd. |
Anticorps semaphorine 3a et leurs utilisations
|
EP3994268A1
(fr)
|
2019-07-04 |
2022-05-11 |
Ukko Inc. |
Alpha gliadine sans épitope et son utilisation pour la gestion de la maladie coeliaque et de la sensibilité au gluten
|
WO2021005599A1
(fr)
|
2019-07-11 |
2021-01-14 |
Kahr Medical Ltd. |
Hétérodimères et procédés d'utilisation correspondants
|
IL268111A
(en)
|
2019-07-16 |
2021-01-31 |
Fainzilber Michael |
Methods of treating pain
|
US20220281960A1
(en)
|
2019-07-16 |
2022-09-08 |
Ramot At Tel-Aviv University Ltd. |
Compositions and methods for the treatment of tuberculosis
|
EP4004548A1
(fr)
|
2019-07-29 |
2022-06-01 |
Yeda Research and Development Co. Ltd |
Procédés de traitement et de diagnostic du cancer du poumon
|
EP4004212A1
(fr)
|
2019-07-30 |
2022-06-01 |
The State of Israel, Ministry of Agriculture & Rural Development, Agricultural Research Organization (ARO) (Volcani Institute) |
Méthodes de régulation de la synthèse de cannabinoïdes chez la plante ou dans des cellules et plantes et cellules ainsi produites
|
EP4014046A1
(fr)
|
2019-08-12 |
2022-06-22 |
Yeda Research and Development Co. Ltd |
Test sanguin de réparation de l'adn pour prédire la réponse de patients atteints d'un cancer du poumon à une immunothérapie
|
WO2021033176A1
(fr)
|
2019-08-22 |
2021-02-25 |
Ariel Scientific Innovations Ltd. |
Procédés mis à l'échelle de purification d'anticorps
|
EP4021463A1
(fr)
|
2019-08-27 |
2022-07-06 |
Yeda Research and Development Co. Ltd |
Traitement de la vaginose bactérienne
|
CA3152511A1
(fr)
|
2019-08-29 |
2021-03-04 |
Vir Biotechnology, Inc. |
Compositions d'anticorps et methodes pour traiter une infection par le virus de l'hepatite b
|
WO2021048852A1
(fr)
|
2019-09-11 |
2021-03-18 |
Yeda Research And Development Co. Ltd. |
Méthodes de traitement du cancer du sein
|
IL269674B
(en)
|
2019-09-25 |
2020-08-31 |
Roy Bar Ziv |
Assembling protein complexes on a chip
|
IL270306A
(en)
|
2019-10-30 |
2021-05-31 |
Yeda Res & Dev |
Prevention and treatment of pre-myeloid and myeloid malignancies
|
US20240117386A1
(en)
|
2019-10-31 |
2024-04-11 |
Yeda Research And Development Co. Ltd. |
Engineered autotrophic bacteria for co2 conversion to organic materials
|
WO2021095031A2
(fr)
|
2019-11-11 |
2021-05-20 |
Ibi-Ag Innovative Bio Insecticides Ltd. |
Nanocorps de lutte contre les insectes et leurs utilisations
|
IL293148A
(en)
|
2019-11-19 |
2024-07-01 |
Protalix Ltd |
Removal of constructs from transduced cells
|
IL270800A
(en)
|
2019-11-20 |
2021-05-31 |
Yeda Res & Dev |
A method for treating Alzheimer's disease
|
KR20220131895A
(ko)
|
2019-11-21 |
2022-09-29 |
인쎄름 (엥스띠뛰 나씨오날 드 라 쌍떼 에 드 라 흐쉐르슈 메디깔) |
항-pd-1/il-15 면역사이토카인을 이용하여 pd-1을 표적으로 하는 신규한 면역요법
|
CN118465272A
(zh)
|
2019-12-04 |
2024-08-09 |
珠海泰诺麦博制药股份有限公司 |
抗人巨细胞病毒抗体及其用途
|
IL271656A
(en)
|
2019-12-22 |
2021-06-30 |
Yeda Res & Dev |
System and methods for identifying cells that have undergone genome editing
|
WO2021130753A1
(fr)
|
2019-12-22 |
2021-07-01 |
Yeda Research And Development Co. Ltd. |
Diagnostic de la démence frontotemporale
|
WO2021137231A1
(fr)
|
2019-12-31 |
2021-07-08 |
Kahr Medical Ltd. |
Procédés de culture de lymphocytes t avec un polypeptide de fusion 4-1bbl et leurs utilisations
|
IL271778A
(en)
|
2019-12-31 |
2021-06-30 |
Ichilov Tech Ltd |
Methods for treating atopic dermatitis
|
WO2021137230A1
(fr)
|
2019-12-31 |
2021-07-08 |
Kahr Medical Ltd. |
Procédés de culture de lymphocytes t et leurs utilisations
|
IL272074B1
(en)
|
2020-01-15 |
2024-08-01 |
Immunity Pharma Ltd |
Peptide compounds and their use in methods of treating diseases
|
IL272194A
(en)
|
2020-01-22 |
2021-07-29 |
Yeda Res & Dev |
Multi-target antibodies for use in the treatment of diseases
|
WO2021152584A1
(fr)
|
2020-01-28 |
2021-08-05 |
Ariel Scientific Innovations Ltd. |
Procédés d'analyse de membranes cellulaires
|
WO2021152586A1
(fr)
|
2020-01-30 |
2021-08-05 |
Yeda Research And Development Co. Ltd. |
Procédés d'analyse du microbiome, du profil d'immunoglobuline et de l'état physiologique
|
WO2021152587A1
(fr)
|
2020-01-30 |
2021-08-05 |
Yeda Research And Development Co. Ltd. |
Traitement d'une maladie hépatique aiguë à l'aide d'inhibiteurs de tlr-mik
|
IL272390A
(en)
|
2020-01-30 |
2021-08-31 |
Yeda Res & Dev |
Cancer treatment methods
|
IL272389A
(en)
|
2020-01-30 |
2021-08-31 |
Yeda Res & Dev |
Kits containing antibodies to PD-L1 and their uses in therapy
|
KR20220151168A
(ko)
|
2020-02-09 |
2022-11-14 |
엔엘씨 파르마 엘티디 |
Sars-cov-2에 대한 신속한 검출 테스트
|
IL272586A
(en)
|
2020-02-10 |
2021-08-31 |
Yeda Res & Dev |
A method for cell cluster analysis
|
WO2021173674A1
(fr)
|
2020-02-26 |
2021-09-02 |
A2 Biotherapeutics, Inc. |
Polypeptides ciblant des complexes mage-a3 peptide-mhc et leurs méthodes d'utilisation
|
WO2021178637A1
(fr)
|
2020-03-05 |
2021-09-10 |
Iowa State University Research Foundation, Inc. |
Compositions immunogènes et vaccinales dirigées contre le sars-cov-2
|
WO2021186431A1
(fr)
|
2020-03-16 |
2021-09-23 |
Yeda Research And Development Co. Ltd. |
Analogues peptidiques et leur utilisation dans le traitement de maladies, troubles ou états associés à une protéine p53 mutante
|
EP4126226A1
(fr)
|
2020-03-29 |
2023-02-08 |
Yeda Research and Development Co. Ltd |
Variants de bêta-glucocérébrosidase destinés à être utilisés dans le traitement de la maladie de gaucher
|
EP4125440A1
(fr)
|
2020-03-31 |
2023-02-08 |
Biomuse Ltd. |
Bactéries destinées à la prévention et au traitement de lésions pulmonaires induites par la fumée
|
EP4133107A1
(fr)
|
2020-04-06 |
2023-02-15 |
Yeda Research and Development Co. Ltd |
Méthodes de diagnostic du cancer et de prédiction de la réactivité à une thérapie
|
EP4132479A1
(fr)
|
2020-04-07 |
2023-02-15 |
Ramot at Tel-Aviv University Ltd. |
Compositions contenant du cannabidiol et leurs utilisations
|
AU2021255132A1
(en)
|
2020-04-13 |
2022-12-08 |
Exoprother Medical Ltd. |
Cell-derived vesicles comprising wild-type P53 protein for antiviral therapy
|
US20210322483A1
(en)
|
2020-04-16 |
2021-10-21 |
Ichilov Tech Ltd. |
Cell-derived particles presenting heterologous cd24 and use thereof in therapy
|
WO2021229577A1
(fr)
|
2020-05-12 |
2021-11-18 |
Collplant Ltd. |
Collagène utilisé comme outil d'administration d'agents antiviraux à base de métaux
|
US20230183366A1
(en)
|
2020-05-13 |
2023-06-15 |
Inserm (Institut National De La Santé Et De La Recherch Médicale) |
Recombinant proteins with ox40 activating properties
|
IL274811B
(en)
|
2020-05-20 |
2021-05-31 |
Yeda Res & Dev |
Spatial information is developed for the analysis of individual cells
|
EP4168438A4
(fr)
|
2020-06-22 |
2024-07-10 |
Univ Ramot |
Modules de protéine à sous-unités multiples, cellules exprimant ceux-ci et leurs utilisations
|
BR112022026316A2
(pt)
|
2020-06-24 |
2023-03-07 |
Vir Biotechnology Inc |
Anticorpos neutralizantes do vírus da hepatite b engenheirados e usos dos mesmos
|
WO2021260675A1
(fr)
|
2020-06-24 |
2021-12-30 |
Yeda Research And Development Co. Ltd. |
Agents pour sensibiliser des tumeurs solides à un traitement
|
IL276599A
(en)
|
2020-08-09 |
2022-03-01 |
Yeda Res & Dev |
T cell receptor unique to mage-a1 and its uses
|
IL276627A
(en)
|
2020-08-10 |
2022-03-01 |
Yeda Res & Dev |
Compositions for diagnosis and treatment of coronavirus infections
|
US20230309480A1
(en)
|
2020-08-18 |
2023-10-05 |
International Rice Research Institute |
Methods of increasing outcrossing rates in gramineae
|
IL277488A
(en)
|
2020-09-21 |
2022-04-01 |
Yeda Res & Dev |
Weight regulation method
|
WO2022064494A2
(fr)
|
2020-09-23 |
2022-03-31 |
Yeda Research And Development Co. Ltd. |
Méthodes et compositions pour traiter des infections à coronavirus
|
IL277743A
(en)
|
2020-10-01 |
2022-04-01 |
Yeda Res & Dev |
A method for diagnosing breast cancer
|
KR20230113283A
(ko)
|
2020-10-05 |
2023-07-28 |
프로탈릭스 리미티드 |
다이서-유사 넉아웃 식물 세포
|
WO2022074656A1
(fr)
|
2020-10-07 |
2022-04-14 |
Protalix Ltd. |
Dnase à action prolongée
|
EP4228637A1
(fr)
|
2020-10-15 |
2023-08-23 |
Yeda Research and Development Co. Ltd |
Méthode de traitement des cancers myéloïdes
|
IL278401A
(en)
|
2020-10-29 |
2022-05-01 |
Yeda Res & Dev |
Polynucleotides for editing RNA and a method for using them
|
EP4240856A2
(fr)
|
2020-11-09 |
2023-09-13 |
1E Therapeutics, Ltd. |
Méthodes de traitement ou de prévention d'infections bactériennes faisant appel à une séquence catalytique
|
WO2022115498A1
(fr)
|
2020-11-26 |
2022-06-02 |
Ukko Inc. |
Sous-unité de gluténine modifiée à poids moléculaire élevé et ses utilisations
|
IL279559A
(en)
|
2020-12-17 |
2022-07-01 |
Yeda Res & Dev |
Controlling the ubiquitination process of mlkl for disease treatment
|
IL304047A
(en)
|
2020-12-28 |
2023-08-01 |
1E Therapeutics Ltd |
Silencing target sites in the p21 mRNA sequence
|
IL304068A
(en)
|
2020-12-28 |
2023-08-01 |
1E Therapeutics Ltd |
DNA enzymes against p21 messenger RNA
|
WO2022149142A2
(fr)
|
2021-01-10 |
2022-07-14 |
Supermeat The Essence Of Meat Ltd. |
Agrégats de cellules souches pluripotentes et microtissus obtenus à partir de ceux-ci pour l'industrie de la viande cultivée
|
US20240083843A1
(en)
|
2021-01-14 |
2024-03-14 |
Yeda Research And Development Co. Ltd. |
Methods of producing vitamin d
|
IL280340B
(en)
|
2021-01-21 |
2022-04-01 |
Yeda Res & Dev |
Antibodies, peptides and their combinations for the treatment and prevention of corona virus infections
|
WO2022164805A1
(fr)
|
2021-01-26 |
2022-08-04 |
Vir Biotechnology, Inc. |
Compositions et méthodes pour traiter une infection par le virus de l'hépatite b
|
JP2024506955A
(ja)
|
2021-02-18 |
2024-02-15 |
イェダ リサーチ アンド デベロップメント カンパニー リミテッド |
ワクチンを作製する方法
|
IL305314A
(en)
|
2021-02-18 |
2023-10-01 |
Yeda res & development co ltd |
A genetically engineered bacterium for vaccine production
|
KR20230154994A
(ko)
|
2021-03-10 |
2023-11-09 |
마빌론 아게 |
Tdp-43에 대한 항체 및 이의 용도
|
IL281561A
(en)
|
2021-03-16 |
2022-10-01 |
Yeda Res & Dev |
Methods and devices for growing mouse embryos outside the uterus
|
WO2022208369A1
(fr)
|
2021-03-30 |
2022-10-06 |
Biomx Ltd. |
Bactériophage de pseudomonas et ses utilisations
|
IL282188A
(en)
|
2021-04-08 |
2022-11-01 |
Yeda Res & Dev |
Combined use of ketamine and bretigabine for the treatment of psychiatric disorders
|
JP2024520907A
(ja)
|
2021-05-12 |
2024-05-27 |
バイオエムエックス・リミテッド |
ブドウ球菌バクテリオファージ及びその使用
|
IL283563A
(en)
|
2021-05-30 |
2022-12-01 |
Yeda Res & Dev |
Profiling of amps for the diagnosis, monitoring and treatment of microbiome-related diseases
|
CA3219233A1
(fr)
|
2021-06-06 |
2022-12-15 |
Ravid STRAUSSMAN |
Traitement combine du cancer
|
IL309333A
(en)
|
2021-06-13 |
2024-02-01 |
Yissum Res Dev Co Of Hebrew Univ Jerusalem Ltd |
A method for reprogramming cells
|
KR20240035997A
(ko)
|
2021-06-16 |
2024-03-19 |
시드엑스 테크놀로지스 인코포레이티드 |
마티올라 종자들을 선별하는 방법들
|
NL2028466B1
(en)
|
2021-06-16 |
2022-12-21 |
Sakata Holland B V |
Methods of sorting matthiola seeds
|
CA3223344A1
(fr)
|
2021-07-02 |
2023-01-05 |
Tropic Biosciences UK Limited |
Retardement ou prevention du brunissement de bananes
|
JP2024526837A
(ja)
|
2021-07-18 |
2024-07-19 |
ガミダ セル リミテッド |
治療用nk細胞集団
|
WO2023002492A1
(fr)
|
2021-07-22 |
2023-01-26 |
Yeda Research And Development Co. Ltd. |
Optimisation de codon d'acides nucléiques
|
EP4380966A2
(fr)
|
2021-08-03 |
2024-06-12 |
Genicity Limited |
Complexe tcr modifié et ses procédés d'utilisation
|
EP4130028A1
(fr)
|
2021-08-03 |
2023-02-08 |
Rhazes Therapeutics Ltd |
Complexe tcr modifié et leurs procédés d'utilisation
|
WO2023018621A1
(fr)
|
2021-08-10 |
2023-02-16 |
Gamida-Cell Ltd. |
Cellules nk modifiées, leurs procédés de production et leurs utilisations
|
GB202112865D0
(en)
|
2021-09-09 |
2021-10-27 |
Tropic Biosciences Uk Ltd |
Resistance to black sigatoka disease in banana
|
GB202112866D0
(en)
|
2021-09-09 |
2021-10-27 |
Tropic Biosciences Uk Ltd |
Resistance to fusarium wilt in a banana
|
IL286430A
(en)
|
2021-09-14 |
2023-04-01 |
Yeda Res & Dev |
Multispecific antibodies for use in the treatment of diseases
|
WO2023105526A1
(fr)
|
2021-12-08 |
2023-06-15 |
Yeda Research And Development Co. Ltd. |
Cellules progénitrices pulmonaires multipotentes pour la régénération pulmonaire
|
WO2023144779A1
(fr)
|
2022-01-28 |
2023-08-03 |
Pfizer Inc. |
Variants d'antigène de coronavirus
|
WO2023209708A1
(fr)
|
2022-04-25 |
2023-11-02 |
Yeda Research And Development Co. Ltd. |
Compositions pour modifier la signalisation de messager secondaire de l'adp-ribose cyclique
|
WO2023242155A1
(fr)
|
2022-06-14 |
2023-12-21 |
Janssen Vaccines & Prevention B.V. |
Compositions et procédés pour le diagnostic d'une infection par le vih
|